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ABSTRACT 
  
Research has shown that spinal cord injury (SCI) can induce neural 
hyperexcitability within the spinal cord that facilitates nociceptive reflexes. Nociceptive 
inputs have been shown to sensitize spinal nociceptive systems, inducing a learning 
deficit and enhanced mechanical reactivity (EMR) in spinally transected rats. 
Nociceptive sensitization has been linked to abnormal GABA-mediated inhibition of 
nociceptive neurons within the spinal cord. However, underlying changes remain poorly 
understood. This dissertation were designed to test the effect of blocking GABA 
transmission on nociceptive sensitization after spinal cord injury. 
Experiment 1 focused on the effect of bicuculline on shock-induced EMR in 
transected rats, finding blocking effect of bicuculline. Experiments 2 and 4 investigated 
whether bicuculline blocks inflammation-induced EMR. I found bicuculline 
pretreatment prevented both LPS and capsaicin-induced EMR. Further, capsaicin-
induced EMR was reversed by bicuculline treatment (Experiment 5). Experiment 6 
found that other GABA receptor antagonists also blocked the capsaicin-induced EMR.  
Of clinical importance, bicuculline blocked indices of capsaicin-induced central 
sensitization at the mRNA level (Experiment 7) and protein level (Experiment 8). These 
results suggest that bicuculline blocks central sensitization in spinally transected rats and 
that GABA has an excitatory effect. 
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To explore whether a spinal transection alters GABA function, similar 
experimental manipulations were conducted in intact rats. Experiment 9 found that 
bicuculline treatment per se induced EMR and failed to block the capsaicin-induced 
EMR. Experiments 10 and 11 found that bicuculline did not block central sensitization at 
the cellular level. These results suggest that GABA inhibits nociceptive processing in 
intact rats, but promotes it after spinal injury. 
Experiment 12 explored that spinal transection induced a downregulation of the 
membrane-bound KCC2, and thereby changed intracellular chloride homeostasis. To test 
whether drug manipulation targeting chloride co-transporters switch the role of GABA 
in nociceptive sensitization, channel blockers targeting KCC2 and NKCC1 were tested. 
Experiment 13 showed that blocking KCC2 in intact rats causes bicuculline to attenuate 
capsaicin-induced EMR. Conversely, Experiment 14 showed that blocking NKCC1 in 
transected rats switches how bicuculline affects capsaicin-induced EMR. Taken together, 
my results suggest that spinal cord injury switches the effect of GABA in nociceptive 
sensitization by altering the intracellular chloride homeostasis.
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CHAPTER I  
INTRODUCTION 
 
Under normal condition, pain (nociceptive stimulation) subserves a protective 
function that promotes learning to avoid dangerous situations and prevent additional 
tissue damage. Nociceptive input begins with a specialized high-threshold nociceptor of 
the sensory system (the nociceptive system) and extends from the periphery (A-delta and 
C-fiber) through the spinal cord to the brain, where the sensation is perceived. When 
tissue damage occurs, injury-induced factors (inflammatory agents) lead to a 
hyperexcitable status of the peripheral nervous system (peripheral sensitization) and shift 
the system from protecting to promoting wound healing (Ji, Kohno, Moore, & Woolf, 
2003). This inflammatory pain often produces allodynia (pain in response to a 
nonnociceptive stimulus) and hyperalgesia (increased pain sensitivity). Nociceptive pain, 
including protective acute pain and inflammation pain usually fade once the painful 
stimulus is removed and/or the wound has healed. However, sometimes pain extends 
beyond the expected period of healing and persists after the stimulus has been removed. 
Pain of this sort is viewed as neuropathic pain, which is associated with injury to the 
peripheral nerve and/or the central nervous system (spinal cord injury [SCI]), or 
sometimes disease (Woolf, 2004). The resulting malfunction of the nervous system has 
been related to changes within neurons (Ji et al., 2003; Woolf, 2004) and between neuro-
glial interaction (Ji & Suter, 2007), that can enhance peripheral and central nociceptive 
processes (peripheral and central sensitization, respectively), and thereby enhance pain 
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by inducing allodynia and/or hyperalgesia. My dissertation examines the mechanisms 
that sensitize nociceptive systems within the spinal cord (central sensitization). 
Evidence suggests that central sensitization is due in part to a change in γ-
Aminobutyric acid (GABA) function (Gwak & Hulsebosch, 2011). Normally, GABA is 
actively modulated by the brain through descending projections (serotonin), and 
subsequently inhibits nociceptive circuits (Ciranna, 2006). Evidence suggests that the 
loss of the descending control from the brain after SCI promotes general 
hyperexcitability in the spinal cord (central sensitization), resulting in the facilitation of 
nociceptive reflexes (Curatolo et al., 2006; Millan, 2002). Here, I explore the possibility 
that this facilitatory effect reflects an alteration in GABA transmission, which causes 
GABA to have an excitatory effect that promotes nociceptive sensitization after SCI. 
To explore how GABA contribute to the hyperexcited nervous system and 
whether GABA can switch from inhibitory to excitatory, I first review the mechanisms 
that sensitize nociceptive systems. Second, I review the role of GABA within 
hyperexcited nervous system. Third, I explain how GABA can have an excitatory effect. 
 
Central Sensitization, Peripheral Sensitization and SCI 
 
Central sensitization, a hyperactive state of nociceptive neurons within dorsal 
horn of the spinal cord, has been suggested to underlie neuropathic pain. It represents a 
condition where input in one set of nociceptor sensory fibers amplifies the subsequent 
responses to other non-stimulated non-nociceptor or nociceptor fibers, known as 
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heterosynaptic potentiation. In this phenomenon, nociceptor inputs can trigger a 
prolonged increase in the excitability and synaptic efficacy of neurons in central 
nociceptive pathways (Woolf & Salter, 2000). Pain hypersensitivity, such as tactile 
allodynia, secondary hyperalgesia, and enhanced temporal summation of action potential 
discharges are observed with central sensitization. The increased synaptic efficacy in 
somatosensory pathway can be attributed to several mechanisms: increased pre-synaptic 
excitatory transmitter release, increased response to the transmitter in the post-synaptic 
portion, increased membrane excitability, or the reduction of inhibition (Latremoliere & 
Woolf, 2009). 
During tissue injury or inflammation, inflammatory mediators induce a 
peripheral sensitization and then ultimately increase the excitability of CNS neurons, 
generating central sensitization (Ji et al., 2003; Woolf, 2004). Peripheral sensitization 
only increases the pain sensitivity in an area that is restricted to the site of inflammation 
or injury, whereas central sensitization can heighten the sensitivity to peripheral region 
of the injury site (secondary hyperalgesia) and to low-threshold mechanosensory input 
(secondary mechanical allodynia). This activity-dependent form of central sensitization 
involves the activation of multiple intracellular signaling pathways including ion-gated 
NMDAR (NMDA receptor) and AMPAR (AMPA receptor), G-protein-coupled 
metabotropic receptors, substance-P receptor neurokinin-1 (NK1), mGluR, and tyrosine 
kinase receptors (trkB and Eph) in dorsal horn neurons (Ji et al., 2003). Central 
sensitization comprises two temporal phases, each with specific mechanisms. The early 
phosphorylation-dependent and transcription-independent phase has been linked to rapid 
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changes in glutamate receptor and ion channel properties. The later, longer-lasting, 
transcription-dependent phase results from the new proteins synthesis that yields a 
longer-lasting form of central sensitization observed in several pathological conditions 
(Ji et al., 2003; Woolf, 2004). 
SCI can produce high concentrations of extracellular glutamate at both 
neuronal-neuronal and neuronal-glial cell appositions. Because neurons and glial cells 
express similar receptors and ion channels, glial activation may trigger similar 
intracellular cascades as those observed in neurons. Briefly, after SCI, high 
concentration of glutamate at neuronal-glial clefts activate the glutamate receptors on 
astrocyte and microglia, both ionotropic and metabotropic. This activation leads to the 
subsequent membrane depolarization that triggers a large influx of Na+ and Ca2+ ions 
(both neuron and glia). Subsequently, the elevated Ca2+ concentrations in astrocytes and 
microglia initiate the activation of mitogen-activated protein kinase (MAPK, p38-MAPK 
and ERK) and phospholipase (PLA2) that result in the modulation of target protein 
expression or phosphorylation of membrane receptor and ion channels through 
activation of transcription factors, such as NF-κB or pCREB (Crown et al., 2006; Gwak 
& Hulsebosch, 2011; Ji et al., 2003). Finally, the activated glial cells release glutamate, 
ATP, proinflammatory cytokines, prostaglandins (PGs), and reactive oxygen (ROS) into 
the extracellular space. These pain mediating substances released by activated glia 
contribute to intracellular downstream biochemical pathways and provide an 
intracellular feed forward mechanism for continued phosphorylation/activation of 
receptors and ion channels. This mechanism ensures the induction and maintenance of 
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the central neuronal hyperexcitability. Glia activation also plays a crucial role in 
developing and maintaining the sensitization of PNS and CNS following SCI.  
 
Inhibitory Tone and SCI 
 
Research within the pain literature has revealed that the GABAergic system 
plays a crucial role in regulating the development of central sensitization and the spinally 
mediated changes induced by peripheral inflammation (Sivilotti & Woolf, 1994; Sluka, 
Willis, & Westlund, 1993, 1994). Under pathological conditions, such as after SCI, the 
inhibitory tone of GABA is modulated. Under normal condition, GABAergic system 
modulates inhibitory tone within the CNS. Treatment of GABAA receptor antagonist 
blocks the inhibitory effect of GABA, sensitizes the CNS, and thereby induces allodynia. 
Contrary to this common view, I hypothesize that the effect of GABA can switch from 
inhibitory to excitatory after SCI, and leads to the hyperexcitable status of CNS. Under 
these conditions, bicuculline could have an anti-allodynic effect. 
Past studies have shown that GABA can have an excitatory effect under certain 
conditions. Ben-Ari et al. (1989) first showed that GABA is excitatory in the immature 
brain. GABA-releasing synapses are formed before glutamatergic contacts in a wide 
range of species and structures (GABAergic synapses are first formed as soon as neurons 
have an apical dendrite). It becomes inhibitory by the delayed expression of a chloride 
exporter, leading to a negative shift in the reversal potential for chloride ions in mature 
brains (Ben-Ari, 2002). The polarity of GABAergic signaling actions depends in part on 
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the intracellular concentration of chloride ([Cl−]i). When Cl− concentration within the 
cell rises, engaging the GABAA receptor can have a depolarizing/excitatory effect. This 
is observed both early in development and in some neurological disorders (Ge et al., 
2006; Gulledge & Stuart, 2003; Marty & Llano, 2005). These changes have been linked 
to alteration in the chloride-extruding- and-uptaking system (NKCC1 and KCC2) which 
regulates intracellular Cl− concentration (Cramer et al., 2008; Hasbargen et al., 2010).  
Other work has implicated central sensitization and GABA in the regulation of 
spinal plasticity (Grau et al., 2006). Prior work from our lab has shown that intermittent 
nociceptive stimulation can induce an over-excitation (hyperexcitable) of the spinal cord, 
and thereby produce a learning deficit and an enhanced mechanical reactivity (EMR; 
Baumbauer et al., 2008, 2012; Ferguson et al., 2003, 2006). Peripheral inflammation 
induced by capsaicin was also shown to impair learning (Hook et al., 2008). The shock-
induced learning deficit has been linked to an alteration in the GABAergic system. 
Supporting this, treatment with bicuculline, a GABAA receptor antagonist, blocks the 
learning impairment (Ferguson et al., 2003). Because treatments that impair spinal 
learning also induce EMR, this finding implies that bicuculline would also block shock-
induced EMR in spinally transected rats. This runs counter to the general view that 
bicuculline treatment should induce EMR by blocking GABAergic inhibition. I suggest 
bicuculline will have this paradoxical anti-allodynic effect in transected animals because 
spinal injury causes a rise in intracellular Cl− that cause GABA to have an excitatory 
effect. 
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Underlying Mechanism of Excitatory GABA 
 
In the nervous system, the strength and polarity of GABA-mediated 
neurotransmission is determined by the intracellular chloride concentration ([Cl-]i), 
because GABAA receptor is an ionotropic channel and selectively conducts Cl- through 
its pore. Cl− concentration is determined, in part, by the activities of the SLC12 cation–
chloride cotransporters (CCCs). These transporters include the Na-K-2Cl cotransporter 
NKCC1, which mediates chloride influx, and various K-Cl cotransporters, such as 
KCC2 and KCC3, that extrude chloride. A precise balance between NKCC1 and KCC2 
activity is necessary for inhibitory GABAergic signaling in the adult CNS, and for 
excitatory GABAergic signaling in the developing CNS and the adult neurogenesis. 
Altered chloride homeostasis, resulting from mutation or dysfunction of NKCC1 and/or 
KCC2, promotes neuronal hypoexcitability. In immature neonatal neurons, the 
intracellular [Cl–]i is about 20–40 mM higher due to robust activity of the chloride-
importing Na-K-2Cl cotransporter NKCC1. The binding of GABA to ligand-gated 
GABAA receptor triggers Cl– efflux and depolarizing excitation. In adults, NKCC1 
expression decreases and the expression of the genetically regulated chloride-extruding 
K-Cl cotransporter KCC2 increases which lowers the [Cl–]i. The activation of 
GABAA receptors triggers Cl– influx and inhibitory hyperpolarization in this 
circumstance. Thus, chloride homeostasis is determined by the balance of NKCC1 and 
KCC2. Targeting these proteins could have clinical value in treating neurological 
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disorders such as spasticity and neuropathic pain (Fukuda, 2005; Jolivalt, Lee, Ramos, & 
Calcutt, 2008). 
Several lines of research have shown that SCI upregulates NKCC1 whereas 
KCC2 is downregulated in the spinal cord, which correlates with allodynia and 
hyperalgesia (Cramer et al., 2008; Hasbargen et al., 2010). The upregulation of NKCC1 
and downregulation of KCC2 produce high intracellular Cl− concentration that facilitates 
efflux of Cl− when GABAA receptor is activated, which generates depolarization 
(excitatory) rather than hyperpolarization (inhibitory). This process may underlie the 
switch of GABA from inhibitory to excitatory after SCI, and the resultant pain 
enhancement. 
 
Specific Aims 
 
When considering GABA effect and the role of GABAA receptor in 
nociceptive plasticity within the spinal cord after SCI, several questions arises: 1) Does 
GABAA receptor bicuculline block the shock-induced EMR after SCI, 2) Does GABAA 
receptor still have inhibitory effect on inflammation induced pain after SCI, 3) Does the 
effect of GABA switch from inhibitory to excitatory after SCI, and 4) If it does switch, 
what is the underlying mechanism?  
The focus of this dissertation is on the role of GABAergic system in 
maladaptive plasticity of nociceptive system (central sensitization) and its underlying 
mechanism. My hypothesis is that GABA switches its effect from inhibitory to 
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excitatory after SCI; and that this biological switch results from the down regulation of 
KCC2 after SCI, which causes the high intracellular Cl− concentration. To test my 
hypothesis, I examined the effect of spinal injury (by transection) and treatment with a 
GABA antagonist on behavioral and cellular indices of central sensitization. First, I 
tested whether the GABAA receptor antagonist, bicuculline, blocks the EMR induced by 
shock or inflammation after SCI (Chapter III). Second, I tested the effect of bicuculline 
on cellular indices of central sensitization (Chapter IV). Third, I tested whether 
bicuculline has different effect in the absence of SCI (Chapter V). Fourth, I explored the 
cellular mechanisms that underlie these effects (Chapter VI). 
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CHAPTER II 
 
GENERAL METHOD 
 
 
 
Subjects 
 
 
 
Subjects were male Sprague-Dawley rats obtained from Harlan (Houston, TX). 
Rats were 70-90 days old and weighted 350-400g at the time of spinal cord transection. 
Food and water were available ad libitum. Subjects were housed in pairs and maintained 
on a 12 hour light-dark cycle. All experiments were carried out in accordance with NIH 
standards for the care and use of laboratory animals (NIH publications No. 80-23) and 
were approved by the University Laboratory Animal Care Committee at Texas A&M 
University. Every effort was made to minimize suffering and limit the number of 
animals used. 
 
Surgery 
 
Subjects were anesthetized with isoflurane gas, induced at 5%, and maintained 
at 2-3%. Each subject’s head was rendered immobile in a stereotaxic apparatus with a 
small (5 X 4 X 2.5 cm) gauze pillow under the subject’s chest to provide support for 
respiration. An anterior to posterior incision over the second thoracic vertebrae (T2) was 
made and the tissue just rostral to T2 was cleared using rongeurs, and the cord was 
exposed and cauterized. The remaining gap in the cord was filled with Gelfoam 
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(Pharmacia Corp., Kalamazoo, MI) and the wound was closed with Michel clips (Fisher 
Scientific, Waltham, MA). Following closure of the wound, intraperitoneal injections (3 
mL) of 0.9% saline solution were administered post-operatively to prevent dehydration. 
Following surgery, rats was placed in a temperature-controlled environment (25.5 °C) 
and monitored until awake. All rats were checked every six to eight hours during the 18-
24 hr post-surgical period. During this time, hydration was maintained with 
supplemental injections of saline, and the rats’ bladders and colons were expressed as 
necessary. 
 
Variable Intermittent Leg Shock 
 
Subjects were treated with electrical stimulation 24 hours after surgery. 
Variable intermittent leg shock was applied while spinalized rats were loosely restrained 
in Plexiglas tubes as previously described (Ferguson et al., 2000; Grau et al., 2006). Leg 
shock was delivered using a BRS/LVE (Laurel, MD) constant current (60 Hz, AC) shock 
generator (Model SG-903). Electrical stimulation was applied by attaching one lead 
from the shock generator to a 2.5 cm stainless steel pin that was inserted 0.4 cm into the 
tibialis anterior muscles. The other lead was inserted through the skin over the tibia, 1.5 
cm from the tarsals. Rats treated with intermittent nociceptive stimulation received 900, 
80-ms leg shocks on a variable time schedule with a mean inter-stimulus interval (ISI) of 
2 s (range 0.2 -3.8 s). Unshocked subjects were placed in the restraining tubes for an 
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equal amount of time as the shocked subjects, had the electrodes attached, but did not 
receive the electrical stimuli. 
 
Drug Administration 
 
Bicuculline (Sigma-Aldrich, St. Louis, MO) was dissolved in 0.9% saline (1 
L). LPS (Sigma-Aldrich, St. Louis, MO) was dissolved in 10 L of 0.9% saline. 
Phaclofen (Santa-Cruz Biotech, Dallas, TX) was dissolved in 1 L of 0.9% saline. 
Gabazine (Sigma-Aldrich, St. Louis, MO) was dissolved in 10 L saline. Twenty g of 
DIOA (Santa-Cruz Biotech, Dallas, TX) was dissolved in 2 L vehicle (DMSO [1%] 
and saline [99%]). One mM of bumetanide (Santa-Cruz Biotech, Dallas, TX) was 
dissolved in 10 L vehicle (Tween20 [2%] and saline [98%]). All the drugs (Table 1) 
mentioned above were intrathecally injected into the subject and followed by a 20 L 
saline (0.9%) flush over a period of 2 min. 
 
Drugs Target IC50 Half-life Loading dose 
Bicuculline GABAA receptor antagonist 3 μM 45min 816 μM 
Gabazine GABAA receptor antagonist 349 nM － 2.715 μM 
271.5 μM 
Phaclofen GABAB receptor antagonist 118 μM 3.4 hr 4 mM 
40 mM 
DIOA KCC2 blocker 50 µM 3.6 hr 50 mM 
Bumetanide NKCC1 antagonist 0.2 μM 0.8hr 
6hr (intravenous 
in neonate) 
1 mM 
Table 1. Pharmacological properties of drugs. IC50 represents the half maximal inhibitory concentration. 
Loading dose represents the dosage used in each experiment. 
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Capsaicin Injection 
 
Three percent capsaicin (Sigma-Aldrich, St. Louis, MO) was dissolved in 50 
L of vehicle (Tween 20 [7%] and saline [93%]) and was injected subcutaneously into 
the dorsal surface of the hindpaw. 
 
Mechanical Reactivity Testing 
 
To determine if stimulation or drug administration produced a change in tactile 
reactivity, thresholds were assessed using von Frey filaments (Stoelting, Wood Dale, IL). 
Sensitivity was determined by stimulating the mid-plantar surface of each hindpaw in an 
ascending order until a flexion response is elicited. Stimuli were presented twice to each 
paw in an ABBA counterbalanced fashion (A = left, B = right), with testing on the same 
leg separated by a 2 min interval. Filament thickness/force is related to behavior using 
the transformation provided by the manufacturer: Intensity = log10 (10,000g). This 
transformation yields a scale that is approximately linear and amenable to parametric 
analyses. Data were converted to change from baseline scores for purposes of analysis. 
 
RNA Extraction and RT-PCR 
 
Subjects were deeply anesthetized with pentobarbital (50mg/kg) and a 1 
centimeter of spinal cord around the lumbar enlargement (L3-L5) was rapidly removed 
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within 3 minute. The spinal cord was further subdivided into dorsal and ventral portions 
for determining the spatial (dorsal-ventral) changes in the expression of genes/proteins 
of interest. The spinal cord specimens were processed for extracting both total RNA 
(RNeasy Mini Kit; Qiagen, Valencia, CA) and total protein (see the protein extraction 
and western blot session). Total RNA (100 ng) was converted into cDNA by TaqMan 
EZ RT-PCR Core reagents (Applied Biosystems, Carlsbad, CA) and the mRNA levels of 
all targets were measured by TaqMan quantitative real-time (RT)-PCR using a 
StepOnePlus™ Real-Time PCR System (Applied Biosystems, Carlsbad, CA.). -actin 
was used as the control gene. The sequences of probes, forward and reverse primers for 
-actin, c-fos, and c-jun, were obtained from Applied Biosystems, Carlsbad, CA. The 
mRNA expression for each gene of interest was normalized to -actin expression, and 
was presented as a fold change increase or decrease in experimental groups relative to 
the sham controls. 
 
Protein Extraction and Western Blot 
 
After RNA extraction, total protein was extracted from the organic layer, using 
the QIAzolTM lysis reagent protocol for isolation of genomic DNA and/or proteins from 
fatty tissue (Qiagen, Valencia, CA). After determining the protein concentration by 
Bradford Assay (BioRad, Hercules, CA), protein samples were diluted in Laemmli 
sample buffer and were stored at -80
o
 C at known concentrations (usually 2-5g/l). 
Western blotting was used for the protein quantification of ERK1/2 and pERK1/2. Equal 
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amounts (30g) of total protein were subjected to SDS-PAGE with 12% Tris-HEPES 
precast gels (Pierce, Rockford, IL) for ERK1/2 and pERK1/2 (~ 42/44 kDa). After 
transfering onto PVDF membranes (Millipore, Bedford, MA) by Bio-Rad Semi-dry 
transfer apparatus, the blots for non-phosphorylated proteins were blocked for one hour 
in 5% blotting grade milk (BioRad, Hercules, CA) in Tris-Buffered Saline Tween-20 
(TBST). Blots for phosphorylated protein (pERK1/2) were blocked in 5% BSA in TBST. 
After blocking, the PVDF membranes were incubated overnight at 4
o
 C in one of the 
following primary antibodies generated in rabbit: ERK1/2 (1:2000; #06-182 - Millipore, 
Temecula, CA), pERK1/2 (1:500; #07-467 - Millipore, Temecula, CA), or - actin 
(1:2500; #Ab8227 - Abcam, Cambridge, MA) which served as the control. All primary 
antibodies were diluted in blocking solution. The following day, PVDF membranes were 
washed in TBST (3 x 5 min) at room temperature and incubated in HRP-conjugated goat 
anti-rabbit or anti-mouse secondary antibodies (1:5,000; #31460 or 31430, respectively; 
Pierce, Rockford, IL) for 1 hour at room temperature. After another 3 x 5 min series of 
washes, the blots were incubated with ECL (Pierce, Rockford, IL) and were imaged with 
Fluorchem HD2 (ProteinSimple, Santa Clara, CA). The protein expression for each gene 
of interest was normalized to -actin expression and presented as a fold change relative 
to the sham controls. Other targets of interest: GAD65/67 (1:500; #Ab1511 - Millipore, 
Temecula, CA), CAMKII (1:1000; #05-532 - Upstate, Lake Placid, NY), BDNF (1:500; 
R-066-500 - Novus Biological, Littleton, CO), TrkB (1:1000; #07-225 - Millipore, 
Temecula, CA), TNF-alpha (1:500; #ARC3012 - Invitrogen, Camarillo, CA), and KCC2 
(1:500; #07-432 - Millipore, Temecula, CA) were assessed in the same fashion. 
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Fractionation 
 
For Experiment 11, the spinal cord specimens were homogenized with dounce 
homogenizer (Kontes) followed by 5 passes through a 22 gauge needle in ice-cold buffer, 
pH 7.5, containing 10 mm Tris, 300 mm sucrose, and a complete mini protease inhibitor 
mixture (Roche). Crude homogenates were centrifuged at 5000 RCF for 5 min at 4°C. 
Supernatant was further fractionated at 13,000 RCF for 30 min. After centrifugation, 
supernatant was collected as cytoplasmic fraction and pellet was resuspended in PBS (50 
μl) containing protease inhibitor as membrane rich fraction. All samples were sonicated 
and stored at −80°C for later processing. N-cadherin was used to confirm plasma 
membrane enrichment. 
 
Statistics 
 
All data were analyzed using an analysis of variance (ANOVA) or an analysis 
of covariance (ANCOVA). For behavioral measures, the individual variability was 
controlled by: (1) Analyzing the test data using an ANCOVA, entering the baseline 
score as a covariate; and (2) Computing a change from baseline score and analyzing the 
data using ANOVA. Both sets of analyses yielded similar patterns of statistical 
significance. An alpha value of .05 or below was considered statistically significant. 
Differences between group means were assessed using Duncan’s New Multiple Range 
post hoc tests when necessary. 
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CHAPTER III 
GABAAR ANTAGONIST’S EFFECT ON EMR IN SPINALLY TRANSECTED RATS 
 
Prior studies have shown that variable intermittent shock (VIS; 900 shocks 
spaced with ISI: 0.2-3.8 s) produces an EMR and a learning deficit in instrumental 
learning (Ferguson et al., 2000; Ferguson et al., 2001). Bicuculline, a GABAA receptor 
antagonist, has been shown to block the induction and expression of the shock-induced 
learning impairment in spinally transected rats (Ferguson et al., 2003). However, the 
effect of bicuculline on EMR has not been tested. Here I examined whether bicuculline 
attenuates VIS-induced EMR in spinally transected rats. Mechanical reactivity was 
accessed using von Frey stimuli applied to the planar surface of each hind paw. Other 
treatments (e.g. lipopolysaccharide and capsaicin) that induce an EMR and learning 
impairment are tested in subsequent experiments. This set of experiments will elucidate 
whether GABA plays a role in the emergence of EMR, which is associated with 
allodynia and sensitization of nociceptive systems (central sensitization) within the 
dorsal horn.  
 
Experiment 1 
 
Experiment 1 examined whether bicuculline blocks the induction of VIS- 
induced EMR in spinally transected rats. 
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Procedure 
The design used in experiments 1-3 is depicted in Figure 1. Spinally-transected 
(at second thoracic vertebra [T2]) and cannulized rat subjects (n=8 per group) were 
microinjected with either saline or 0.3% bicuculline (Ferguson et al., 2003) through the 
intrathecal catheter. Fifteen minutes after drug delivery, subjects received either VIS or 
nothing (unshock). This yielded a 2 (bicuculline vs. vehicle) X 2 (variable shock vs. 
unshocked) factorial design. Tactile reactivity was assessed on each paw prior to drug 
delivery (baseline), prior to leg shock, and again 0, 1, 2, 3 hr following shock treatment. 
A change from baseline score was also calculated to assess the impact of experimental 
manipulations. 
 
Figure 1. Experimental design for Experiment 1-3. 
 
Results 
Prior to drug treatment, mean baseline tactile reactive scores ranged from 6.27 
± 0.06 to 6.33 ± 0.06 (mean ± standard error of the mean [SE]) across groups. These 
differences were not statistically significant, all Fs < 1.0, p > .05.  
The effect of bicuculline on shock-induced EMR is depicted in Figure 2. 
Before shock treatment (Post Drug) bicuculline did not have a significant effect, F (3, 28) 
< 1.0, p > .05. As in previous studies (Ferguson et al., 2000; Ferguson et al., 2001), 
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shock (Post Shock) induced EMR in vehicle treated rats (Veh-Veh). Pretreatment with 
bicuculline blocked the development of EMR (Bic-Shk).  
I first analyzed the raw data (Figure 2A). To control for variation in baseline 
reactivity, baseline scores were entered as a covariate using an analysis of covariance 
(ANCOVA). Both the main effect of bicuculline treatment and its interaction with shock 
were statistically significant, both Fs > 5.48, p < .05. The ANCOVA also revealed a 
significant time x shock interaction, F (3, 81) = 2.78, p < .05. No other terms were 
statistically significant, all Fs < 2.78, p > .05. Post hoc comparison confirmed that the 
vehicle treated group that received shock (Veh-Shk) differed from the other groups, p 
< .05. No other group comparison was significant, p > .05. 
Variation in baseline reactivity can also be addressed by computing a change 
from baseline score (Figure 2B). An analysis of variance (ANOVA) performed on the 
post shock scores again yielded a significant main effect of bicuculline treatment and 
bicuculline by shock interaction, both Fs > 5.71, p < .05. The ANOVA also revealed a 
significant time x shock interaction, F (3, 81) = 2.8, p < .05. No other terms were 
statistically significant, all Fs < 2.02, p > .05. Post hoc comparison confirmed that the 
vehicle treated group that received shock (Veh-Shk) differed from the other groups, p 
< .05. No other group comparisons were significant, p > .05. 
An advantage of the change from baseline score is that our index of group 
reactivity (the standard error of the mean [SE]) is computed after we adjust for 
individual variability. Consequently, it is easier to judge relative group differences. For 
this reason, and because an ANCOVA performed on the raw scores, and an ANOVA 
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conducted on the change from baseline values, yielded the same pattern of significance 
in all subsequent experiments, only the latter is reported. 
 
Vehicle 
X 
Unshock 
Bicuculline Shock 
 
Figure 2. Bicuculline blocked shock-induced EMR. (A) Subjects that received bicuculline (Bic) or its 
vehicle (Veh) are depicted as squares and circles, respectively. Groups given VIS (Shk) or nothing (Unshk) 
are shown in black and white, respectively. The left y-axis depicts linearized tactile scores based on a 
transformation (log 10 [10,000g]) of the force required to bend the thinnest filament that produced paw 
withdraw after bicuculline treatment (Post Drug), and were then reassessed at 0, 1, 2, 3 hr after VIS 
treatment (Post Shock). The right y-axis depicts the gram force equivalents. (B) The change from baseline 
scores. The error bars depict ± SEM. 
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Discussion   
Replicating previous results, VIS induced a lasting EMR. As predicted, this 
effect was blocked by pretreatment with the GABAA antagonist bicuculline. 
 
Experiment 2 
 
Experiment 1 showed that bicuculline pre-treatment blocks VIS-induced EMR. 
Experiments 2 and 3 examine the generality of this effect. The endotoxin, 
lipopolysaccharide (LPS), elicits a strong immune response in animals and induces both 
EMR (allodynia and hyperalgesia) and a spinally-mediated learning impairment (Reeve, 
Patel, Fox, Walker, & Urban, 2000; Vichaya et al., 2009; Young, Baumbauer, Elliot, & 
Joynes, 2007). LPS-induced EMR has been shown to correlate with the increase of 
peripheral and central proinflammatory cytokines such as TNF, IL-1, and IL-6 that 
modulate pain response following injury (Kanaan et al., 2000; Watkins, Maier, & 
Goehler, 1995). The present experiment examines whether GABA plays a role in LPS-
induced EMR. 
Procedure 
The design of experiment 2 is analogous to that used in Experiment 1 (Figure 
1). Spinally-transected and cannulized rat subjects (n=8 per group) were microinjected 
with either vehicle or 0.3% bicuculline through an intrathecal (i.t.) catheter. Fifteen 
minutes after drug delivery, subjects in each group received either 100 g LPS or 
vehicle (i.t.). This yielded a 2 (bicuculline vs. vehicle) X 2 (LPS vs. vehicle) factorial 
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design. Tactile reactivity was assessed on each paw prior to drug delivery (baseline), 
prior to LPS treatment, and again 0, 1, 2, 3 hr after LPS injection. 
 Results 
Prior to treatment, mean baseline scores ranged from 6.26 ± 0.05 to 6.36 ± 0.62 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 1.0, p > .05. 
 The effect of bicuculline on LPS-induced EMR is depicted in Figure 3. Before 
LPS treatment, bicuculline administration (Post Drug) had no effect on mechanical 
reactivity, F (3, 20) < 1.0, p > .05. LPS treatment (Post LPS) induced an EMR that lasted 
3 hr (Veh-LPS). This effect was blocked by pretreatment with bicuculline (Bic-LPS). An 
ANOVA performed on the change from baseline scores revealed a significant main 
effect of LPS, F (1, 20) = 5.71, p < .05, and bicuculline treatment, F (1, 20) = 9.28, p 
< .05. Also, the LPS x bicuculline interaction was significant, F (1, 20) = 6.16, p < .05. 
No other terms were statistically significant, all Fs < 2.49, p > .05. Post hoc comparison 
confirmed that the group that received LPS alone (Veh-LPS) differed from the other 
groups, p < .05. No other group comparisons was significant, p > .05. 
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Vehicle 
X 
Vehicle 
Bicuculline LPS 
 
 
Figure 3. Bicuculline blocked LPS-induced EMR. (A) Subjects that received bicuculline (Bic) or its 
vehicle (Veh) are depicted as squares and circles, respectively. Groups with LPS or vehicle are shown in 
black and white, respectively. The left y-axis depicts linearized tactile scores based on a transformation 
(log 10 [10,000g]) of the force required to bend the thinnest filament that produced a paw withdraw. 
Tactile reactivity was reassessed after bicuculline treatment (Post Drug), and again at 0, 1, 2, 3 hr after 
LPS (Post LPS). The right y-axis depicts the gram force equivalents. (B) The change from baseline scores. 
The error bars depict ± SEM. 
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Discussion   
As expected, LPS induced a lasting EMR. Pretreatment with bicuculline 
blocked the LPS-induced EMR. These data extend the generality of my finding and 
suggest that GABAergic system plays a critical role in inflammation-induced 
mechanical hypersensitivity. 
 
Experiment 3 
 
Experiment 2 showed that bicuculline blocks the induction of LPS-induced 
EMR. However, manipulations that affect the induction of EMR do not always prove 
capable of reversing the EMR after it has been induced. Whether drug treatment affects 
EMR after it is induced is especially important to clinical applications. The present 
experiment examined whether GABA plays a role in the maintenance of LPS-induced 
EMR.  
Procedure 
The design of experiment 3 is depicted in Figure 4. Spinally transected and 
cannulized subjects (n=8 per condition) were randomly assigned to one of three 
treatments: vehicle before LPS (Veh-LPS), bicuculline before LPS (Bic-LPS), and 
bicuculline given one hour after LPS (LPS-Bic). In the first two groups, bicuculline or 
its vehicle were given (i.t.) prior to LPS treatment. Fifteen minutes after drug delivery, 
subjects in each group received intrathecal LPS. Tactile reactivity was assessed on each 
paw prior to drug delivery (baseline), prior to LPS injection, and again at 0, 1, 2, 3 hr 
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following LPS treatment. In the third group (LPS-Bic), bicuculline (i.t.) was 
administered immediately after the tactile test 1 hour after LPS treatment. As reported 
above, the pattern of statistical significance was the same independent of whether the 
raw scores or a change from baseline scores were analyzed. For this reason, I focus on 
the change from baseline scores in this experiment. 
 
Figure 4. Experimental design for Experiment 3. 
 
Results 
Prior to treatment, mean baseline scores ranged from 6.20 ± 0.04 to 6.3 ± 0.08 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 1.0, p > .05.  
The effect of bicuculline on the maintenance of LPS-induced EMR is depicted 
in Figure 5. Before LPS treatment, bicuculline administration (Post Drug) had no effect 
on mechanical reactivity, F (2, 21) < 1.0, p > .05. In the first hour (0-1 hr) after LPS 
treatment, LPS (Post LPS) induced a significant EMR (Veh-LPS and LPS-Bic). This 
effect was blocked by bicuculline pretreatment (Bic-LPS), replicating the results of 
Experiment 2. An ANOVA showed that the groups were significantly different, F (2, 21) 
= 10.32, p < .05. Also, the main effect of time, and its interaction with treatment were 
statistically significant, all Fs > 3.69, p < .05. Post hoc comparisons of the 0-1 hr means 
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confirmed that the group received bicuculline pretreatment (Bic-LPS) differed from the 
other groups, p < .05. No other group comparisons were significant, p > .05. 
During the second and third hour, bicuculline treatment after LPS (LPS-Bic) 
failed to reverse the LPS-induced EMR. An ANOVA revealed a significant effect of 
treatment, F (2, 21) = 5.46, p < .05. No other term was significant, all Fs < 1.64, p > .05. 
Post hoc comparisons of the 2-3 hr means confirmed that the group that received 
bicuculline pretreatment alone (Veh-Cap) differed from the other groups, p < .05. No 
other group comparison was significant, p > .05. 
 
 
Figure 5. Bicuculline blocked but failed to reverse LPS-induced EMR. Subjects that received vehicle and 
LPS (Veh-LPS) are depicted as open circles, subjects that received bicuculline before LPS (Bic-LPS) are 
depicted as black circles, and subjects that received bicuculline 1hr after LPS are depicted as open squares 
(LPS-Bic). The y-axis depicts the change from baseline after drug treatment (Post Drug), and 0, 1, 2, 3 hr 
after LPS treatment (Post LPS). The error bars depict ± SEM. 
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Discussion   
Bicuculline pretreatment blocked the LPS-induced EMR, replicating the result 
from Experiment 2. However, bicuculline treatment 1 hr after LPS failed to reverse the 
LPS-induced EMR. These data imply that the GABAA receptor plays a critical role in 
the induction but not maintenance of LPS-induced EMR. 
 
Experiment 4 
 
Experiments 1 and 2 showed that the GABAA receptor antagonist bicuculline 
blocks the induction of shock and LPS induced EMR. These results suggest that spinal 
GABAA receptor transmission is a crucial component of the signaling cascade for 
enhanced mechanical reactivity. Elsewhere, Grau and his colleagues (Grau et al., 2006; 
Grau et al., 2014; Vichaya et al., 2009; Young et al., 2007) have suggested that VIS and 
LPS impair learning, and induce EMR, because these treatments diffusely sensitize 
spinal nociceptive systems (central sensitization). A more direct test of this hypothesis 
was provided by examining the impact of peripheral treatment with the irritant capsaicin. 
Capsaicin, a molecule that selectively binds to the TRPV1 receptor, has been widely 
used as a pain model (Caterina et al., 1997). It has also been shown to induce EMR and a 
learning deficit in spinalized rats (Hook et al., 2008). The activation of the TRPV1 
receptor by capsaicin induces peripheral sensitization and ultimately increases the 
excitability of CNS neurons (central sensitization, Ji et al., 2003; Woolf, 2011). Here I 
examined whether bicuculline blocks capsaicin-induced EMR in spinally transected rats. 
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Procedure 
The design of experiment 3 was analogous to that used in Experiments 1 and 2 
(Figure 1). Spinally-transected and cannulized rat subjects (n=6 per group) were 
microinjected with either vehicle or 0.3% bicuculline through the intrathecal catheter 
(i.t.). Fifteen minutes after drug delivery, subjects in each group received either 
intradermal 3% capsaicin or its vehicle in the left or right hind paw (counter-balanced 
across subjects). This yielded a 2 (bicuculline vs. saline) X 2 (capsaicin vs. vehicle) 
factorial design. Tactile reactivity was assessed on each paw prior to drug delivery 
(baseline), prior to capsaicin injection, and again 0, 1, 2, 3 hr after capsaicin treatment.  
 Results 
Prior to treatment, mean baseline scores ranged from 6.10 ± 0.05 to 6.29 ± 0.1 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 2.65, p > .05.  
The effect of bicuculline on capsaicin-induced EMR is depicted in Figure 6. 
Before capsaicin treatment, bicuculline administration (Post Drug) had no effect on 
mechanical reactivity, F (3, 20) = 1.1, p > .05. As expected, capsaicin induced a weaker 
EMR on the untreated leg (Figure 6C and 6B; -0.13 ± 0.03) relative to the treated leg 
(Figure 6A and 6B; -0.5 ± 0.03), F (1, 20) = 8.37, p < .05. Nevertheless, the overall 
pattern of results was similar on both legs. Capsaicin treatment (Post Cap) induced a 
lasting EMR (Veh-Cap) and this effect was blocked by pretreatment with bicuculline 
(Bic-Cap).  
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Because similar results were obtained across legs (Figure 6E and 6F) in this 
and subsequent experiments, we collapsed the data across tested leg. An ANOVA 
performed on the mean change from baseline scores showed that the main effect of 
capsaicin and bicuculline, as well as their interaction, were significant, all Fs > 47.55, p 
< .05. The time x capsaicin interaction and the three-way interaction of time x capsaicin 
x bicuculline were also statistically significant, all Fs > 2.9, p < .05. No other terms were 
statistically significant, all Fs < 4.18, p > .05. Post hoc comparison confirmed the group 
that received capsaicin alone (Veh-Cap) differed from the other groups, p < .05. No 
other group comparison was significant, p > .05. 
Vehicle 
X 
Vehicle 
Bicuculline Capsaicin 
Treated leg 
Figure 6. Bicuculline blocked capsaicin induced EMR. Subjects that received bicuculline (Bic) or its 
vehicle (Veh) are depicted as squares and circles, respectively. Groups treated with capsaicin (Cap) or its 
vehicle (Veh) are shown in black and white, respectively. (A) Raw data of capsaicin-treated leg. The left 
y-axis depicts linearized tactile scores based on a transformation (log 10 [10,000g]) of the force required 
to bend the thinnest filament that produced a paw withdraw. Mechanical reactivity was tested after 
bicuculline treatment (Post Drug), and again at 0, 1, 2, 3 hr after capsaicin (Post Cap). The right y-axis 
depicts the gram force equivalents. (B) The change from baseline scores of capsaicin-treated leg. (C) Raw 
data of untreated leg. (D) The change from baseline scores of untreated leg. (E) Raw data collapsed across 
test leg. (F) The change from baseline scores averaged over test leg. The error bars depict ± SEM. 
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Untreated leg 
Average across test leg 
Figure 6. Continued.
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Discussion   
Capsaicin induced a lasting EMR, replicating previous results (Hook et al., 
2008). Pretreatment with bicuculline blocked the capsaicin-induced EMR implying that 
GABAergic neurons play a role in inflammation-induced EMR. 
 
Experiment 5 
 
Experiment 4 showed that bicuculline blocks the induction of capsaicin-
induced EMR. However, manipulations that affect the induction of central sensitization 
do not always prove capable of reversing the EMR after it has been induced (Grau et al., 
2014; Sluka et al., 1994). Whether drug treatment affects central sensitization after it is 
induced is especially important to clinical applications. The present experiment 
examined whether GABA plays a role in the maintenance of capsaicin-induced EMR.  
Procedure 
The design of experiment 5 is depicted in Figure 7. Spinally transected and 
cannulized subjects (n=6 per condition) were randomly assigned to one of three 
treatments: vehicle before capsaicin (Veh-Cap), bicuculline before capsaicin (Bic-Cap), 
and bicuculline given one hour after capsaicin (Cap-Bic). In the first two groups, 
bicuculline or its vehicle were given (i.t.) prior to capsaicin treatment. Fifteen minutes 
after drug delivery, subjects in each group received intradermal capsaicin in the left or 
right hind paw (counter-balanced across subjects). Tactile reactivity was assessed on 
each paw prior to drug delivery (baseline), prior to capsaicin injection, and again at 0, 1, 
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2, 3 hr following capsaicin treatment. In the third group (Cap-Bic), bicuculline (i.t.) was 
administered immediately after the tactile test 1 hour after capsaicin treatment. As 
reported above, the pattern of statistical significance was the same independent of 
whether the raw scores or a change from baseline scores were analyzed. Likewise, while 
a weaker effect was observed on the untreated leg, the overall pattern was the same. For 
these reasons, I focus on the change from baseline scores, collapsed across the treated 
and untreated legs, in this and subsequent experiments. 
 
Figure 7. Experimental design for Experiment 5. 
 
Results 
Prior to treatment, mean baseline scores ranged from 6.12 ± 0.07 to 6.19 ± 0.12 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 1.0, p > .05.  
The effect of bicuculline on the maintenance of capsaicin-induced EMR is 
depicted in Figure 8. Before capsaicin treatment, bicuculline administration (Post Drug) 
had no effect on mechanical reactivity, F (2, 15) < 1.0, p > .05. In the first hour (0-1 hr) 
after capsaicin treatment, capsaicin (Post Cap) induced a significant EMR (Veh-Cap and 
Cap-Bic). This effect was blocked by bicuculline pretreatment (Bic-Cap), replicating the 
results of Experiment 4. An ANOVA showed that the groups were significantly different, 
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F (2, 15) = 9.93, p < .05. Also, the main effect of time, and its interaction with treatment 
were statistically significant, all Fs > 8.35, p < .05. No other term was significant, all Fs 
< 3.35, p > .05. Post hoc comparisons of the 0-1 hr means confirmed that the group 
received bicuculline pretreatment (Bic-Cap) differed from the other groups, p < .05. No 
other group comparisons were significant, p > .05. 
During the second and third hour, bicuculline treatment after capsaicin (Cap-
Bic) reversed the capsaicin-induced EMR. An ANOVA revealed a significant effect of 
treatment, F (2, 15) = 12.67, p < .05. No other term was significant, all Fs < 2.04, p 
> .05. Post hoc comparisons of the 2-3 hr means confirmed that the group that received 
capsaicin alone (Veh-Cap) differed from the other groups, p < .05. No other group 
comparison was significant, p > .05. 
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Figure 8. Bicuculline blocked and reversed capsaicin-induced EMR. Subjects that received vehicle and 
capsaicin (Veh-Cap) are depicted as open circles, subjects that received bicuculline before capsaicin (Bic-
Cap) are depicted as black circles, and subjects that received bicuculline 1hr after capsaicin are depicted as 
open squares (Cap-Bic). (A) The change from baseline scores of capsaicin-treated leg. The y-axis depicts 
the change from baseline after drug treatment (Post Drug), and 0, 1, 2, 3 hr after capsaicin treatment (Post 
Cap). (B) The change from baseline scores of untreated leg. (C) The change from baseline scores 
collapsed across test leg. The error bars depict ± SEM. 
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Discussion   
Capsaicin induced a lasting EMR, replicating the result from Experiment 4. 
Bicuculline treatment blocked and reversed the capsaicin-induced EMR. These data 
imply that the GABAA receptor plays a critical role in both the induction and 
maintenance of capsaicin-induced EMR. 
 
Experiment 6 
 
Experiments 4 and 5 showed that the GABAA receptor antagonist bicucullilne 
can block and reverse capsaicin-induced EMR in transected rats. However, bicuculline 
also affects Ca2+-activated potassium channels (Khawaled, Bruening-Wright, Adelman, 
& Maylie, 1999). Given this, I sought further evidence that the GABAA receptor plays a 
critical role. This was accomplished by assessing the impact of another GABAA receptor 
antagonist (gabazine) on capsaicin-induced EMR in transected rats. This experiment also 
explores whether a GABAB receptor antagonist (phaclofen) affects capsaicin-induced 
EMR (Malan, Mata, & Porreca, 2002). 
Procedure 
The design of experiment 6 is depicted in Figure 9. Spinally-transected and 
cannulized rat subjects (n=6 per group) were microinjected with either saline or one of 
three doses of gabazine (Figure 9A; 0.0 [vehicle], 0.001, 0.01 μg) or phaclofen (Figure 
9B; 0.0 [vehicle], 1, 10 μg) through intrathecal catheter (i.t.). Fifteen minutes after drug 
delivery, subjects in each group received intradermal capsaicin to the left or right hind 
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paw (counter-balanced across subjects). Tactile reactivity was assessed on each paw 
prior to drug delivery (baseline), prior to capsaicin injection, and again 0, 1, 2, 3 hr 
following capsaicin treatment.  
A 
 
B 
Figure 9. Experimental design for Experiment 6. 
 
Results 
Prior to gabazine or phaclofen treatment, mean baseline scores ranged from 
5.99 ± 0.04 to 6.28 ± 0.14 (mean ± standard error of the mean [SE]) across groups. These 
differences were not statistically significant, all Fs < 1.7, p > .05.  
The effect of gabazine on capsaicin-induced EMR is depicted in Figure 10A. 
Before capsaicin treatment, drug administration (Post Drug) had no effect on mechanical 
reactivity, F (2, 15) < 1.0, p > .05. Capsaicin treatment (Post Cap) induced a lasting 
EMR (Veh-Cap). This effect was blocked by pretreatment with gabazine (GBZ 0.01, 
GBZ 0.001). An ANOVA showed that the main effect of drug and time, as well as their 
interaction, were statistically significant, all Fs > 29.5, p < .05. No other term was 
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statistically significant, all Fs < 1.0, p > .05. Post hoc comparison confirmed that the 
group that received capsaicin alone (Vehicle) differed from the other groups, p < .05. 
The effect of phaclofen on capsaicin-induced EMR is depicted in Figure 10B. 
Before capsaicin treatment, drug administration (Post Drug) had no effect on mechanical 
reactivity, F (2, 15) = 1.84, p > .05. Capsaicin treatment (Post Cap) induced a lasting 
EMR (Veh-Cap). This effect was blocked by pretreatment with both dosages of 
phaclofen (Phaclofen 1, Phaclofen 10). An ANOVA showed that the main effect of drug 
and time, as well as their interaction, were statistically significant, all Fs > 11.64, p < .05. 
No other term was significant, all Fs < 1.77, p > .05. Post hoc comparisons confirmed 
that the group that received capsaicin alone (Vehicle) differed from the other groups, p 
< .05. 
 
 
Figure 10. Gabazine and phaclofen blocked capsaicin-induced EMR. Subjects that received gabazine 
(GBZ) are shown in squares, subjects that received phaclofen are shown in circles, and subjects that 
received vehicle are shown in triangles. (A) Effect of gabazine on capsaicin induced EMR. The y-axis 
depicts the change from baseline after drug treatment (Post Drug), and 0, 1, 2, 3 hr after capsaicin 
treatment (Post Cap). (B) Effect of phaclofen on capsaicin induced EMR. The error bars depict ± SEM. 
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Discussion 
Capsaicin induced a lasting EMR, replicating Experiment 4. Both gabazine and 
phaclofen treatment blocked the capsaicin-induced EMR. These data provide further 
evidence that GABAergic transmission plays a critical role in inflammation-induced 
EMR. While both drugs attenuated capsaicin-induced EMR, only gabazine appeared to 
fully block this effect, and a significant difference between these two groups was shown. 
Presumably, this difference in effectiveness is due to difference in how GABAA versus 
GABAB receptors affect cellular function, and/or where the receptors are localized. I will 
discuss these issues in more detail in the General Discussion. 
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CHAPTER IV 
GABAAR ANTAGONIST’S EFFECT ON CELLULAR INDICES OF CENTRAL 
SENSITIZATION 
 
The previous experiments showed that blocking the GABAA receptor 
eliminates shock and inflammation induced EMR after SCI (Chapter III).  These results 
suggest that GABAergic mechanisms play a crucial role in EMR induction and 
expression after spinal transection. The results also imply that these GABAergic systems 
are involved in the sensitization of nociceptive processes (central sensitization) within 
the dorsal horn. Behaviorally, central sensitization is evident from pain hypersensitivity, 
tactile allodynia, and secondary punctate or pressure hyperalgesia. At a cellular level, 
central sensitization is associated with increased expression of the immediate early gene 
c-fos and phosphorylation of the protein ERK. Here I examine whether bicuculline 
treatment impacts these cellular indices of central sensitization. 
 
Experiment 7 
 
The induction of central sensitization is correlated with the activation of the 
immediate early proto-oncogene c-fos within the dorsal horn (Gao & Ji, 2009). In this 
experiment, I tested whether bicuculline treatment attenuates capsaicin-induced c-fos 
expression using qRT-PCR. Another early transcription factor gene, c-jun, which forms 
AP-1 early response transcription factor in combination with c-fos, was also assessed. 
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Procedure 
The design of Experiment 7 is similar to that used in Experiment 4 (see Figure 
1). The one change is that von Frey mechanical testing was only conducted for 2 hr after 
capsaicin treatment. Immediately after the last behavior test, subjects (n=6 per group) 
were sacrificed. A 1 centimeter of spinal cord around the lumbar enlargement (L3-L5) 
region was rapidly removed. The spinal cord samples were hemi-dissected into dorsal 
and ventral halves, and were then subjected to RNA extraction for qRT-PCR. 
 Results 
Prior to treatment, mean baseline scores ranged from 6.16 ± 0.02 to 6.24 ± 0.06 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 2.69, p > .05. 
The behavioral data are depicted in Figure 11. Before capsaicin treatment, 
bicuculline administration (Post Drug) had no effect on mechanical reactivity, F (3, 20) 
= 2.5, p > .05. Replicating the previous result (Experiment 4), capsaicin treatment (Post 
Cap) induced a lasting EMR (Veh-Cap). This effect was blocked by pretreatment with 
bicuculline (Bic-Cap). An ANOVA showed that the main effect of capsaicin and 
bicuculline, as well as their interaction, were significant, all Fs > 17.71, p < .05. Also, 
the main effect of time, and its interaction with bicuculline and capsaicin, as well as the 
time x capsaicin x bicuculline three-way interaction were statistically significant, all Fs 
> 3.38, p < .05. Post hoc comparisons confirmed that the group that received capsaicin 
alone (Veh-Cap) differed from the other groups, p < .05. In addition, the group that 
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received bicuculline before capsaicin (Bic-Cap) differed from the other three groups, p 
< .05. No other group comparison was significant, p > .05. 
 
Vehicle 
X 
Vehicle 
Bicuculline Capsaicin 
 
Figure 11. Bicuculline blocked capsaicin-induced EMR. Subjects that received bicuculline (Bic) or 
vehicle (Veh) are depicted as squares and circles, respectively. Groups treated with capsaicin (Cap) or its 
vehicle (Veh) are shown in black and white, respectively. The y-axis depicts the change from baseline 
after bicuculline treatment (Post Drug), and 0, 1, 2 hr after capsaicin treatment (Post Cap). The error bars 
depict ± SEM. 
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The PCR results are depicted in Figure 12. The mRNA expression for each 
gene of interest was normalized to -actin expression level, and is presented as a fold 
change relative to the sham controls. In the dorsal region (Figure 12A), capsaicin 
induced an increase in c-fos mRNA expression level. Bicuculline pretreatment reduced 
the capsaicin induced elevation of c-fos level. An ANOVA revealed a significant main 
effect of capsaicin treatment, F (1, 20) = 23.88, p < .05. No other terms were statistically 
significant, all Fs < 3.42, p > .05. Post hoc comparisons confirmed that the group that 
received bicuculline before capsaicin (Bic-Cap) differed from the other groups, p < .05. 
Also, the group that received capsaicin alone (Veh-Cap) differed from the other groups, 
p < .05. No other group comparison was significant, p > .05.  
In the ventral region (Figure 12B), capsaicin induced an increase in c-fos 
mRNA expression level that was not affected by bicuculline pretreatment. An ANOVA 
showed that the main effect of capsaicin treatment was statistically significant, F (1, 20) 
= 21.22, p < .05. No other term was significant, all Fs < 1.0, p > .05. Post hoc 
comparisons showed that the groups that received capsaicin alone (Veh-Cap) and 
bicuculline before capsaicin (Bic-Cap) were significantly different from the groups that 
received bicuculline alone (Bic-Veh) and the control group (Veh-Veh), p < .05. No other 
group comparison was significant, p > .05. 
Capsaicin treatment also induced an increase in c-jun mRNA expression level 
within the dorsal horn (Figure 12A). However, bicuculline pretreatment did not reduce 
c-jun expression. An ANOVA revealed a significant main effect of capsaicin treatment, 
F (1, 20) = 13.64, p < .05. No other term was statistically significant, all Fs < 4.17, p 
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> .05. Post hoc comparisons confirmed that the group that received capsaicin alone 
(Veh-Cap) differed from the control group (Veh-Veh) and bicuculline alone group (Bic-
Veh). Also, the group that received bicuculline before capsaicin (Bic-Cap) differed from 
the bicuculline alone group (Bic-Veh). No other group comparison was significant, p 
> .05. 
A similar pattern of c-jun mRNA expression level was observed within the 
ventral horn (Figure 12B). An ANOVA revealed a significant main effect of capsaicin 
treatment, F (1, 20) = 22.47, p < .05. No other term was statistically significant, all Fs < 
1.84, p > .05. Post hoc comparisons showed that the groups that received capsaicin alone 
(Veh-Cap) and bicuculline before capsaicin (Bic-Cap) were significantly different from 
the groups that received bicuculline alone (Bic-Veh) and the control group (Veh-Veh), p 
< .05. No other group comparison was significant, p > .05. 
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Figure 12. mRNA expression levels after bicuculline and capsaicin treatment. (A) mRNA expression level 
of c-fos and c-jun in the dorsal region of the spinal cord. Bicuculline (Bic) or saline (Veh) treatment are 
shown on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are shown in white and 
black bars, respectively. The y-axis depicts the fold change in mRNA expression for each group relative to 
the control (Veh-Veh) (B) mRNA expression level of c-fos and c-jun in the ventral region of the spinal 
cord. The error bars depict ± SEM. 
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Discussion   
As found in Experiment 4, pretreatment with bicuculline blocked the 
capsaicin-induced EMR. Here, I showed that bicuculline also attenuates c-fos mRNA 
expression within the dorsal horn, a cellular index of central sensitization. 
 
Experiment 8 
 
Experiment 7 showed that bicuculline attenuates capsaicin-induced c-fos 
mRNA expression level within the dorsal horn. Here I examine another cellular marker 
of central sensitization, the phosphorylation of ERK protein (Gao & Ji, 2009). 
Procedure 
After RNA extraction in Experiment 7, total protein was extracted from the 
organic layer of the 48 samples (24 dorsal, 24 ventral), and was used for Western 
Blotting. The protein expression for each target was normalized to -actin expression 
level, and was presented as a fold change relative to the sham controls. Subsequently, the 
protein expression of pERK1/2 was normalized to ERK1/2 expression yielding a 
pERK/ERK ratio. Other proteins of interest including CaMKII, BDNF, GAD65/67, 
TrkB92/145, TNF- were also tested. 
 Results 
ERK protein levels are depicted in Figure 13. In the dorsal region (Figure 13A), 
capsaicin induced an increase in ERK phosphorylation (pERK ratio) for both ERK1 
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(ERK42) and ERK2 (ERK44). Bicuculline pretreatment reduced the capsaicin induced 
elevation of ERK phosphorylation ratio in both ERK isoforms. For ERK1, an ANOVA 
revealed a significant main effect of capsaicin treatment, F (1, 20) = 6.98, p < .05. For 
ERK2, an ANOVA showed that the main effect of capsaicin and bicuculline, as well as 
their interaction, were statistically significant, all Fs > 5.32, p < .05. No other term was 
statistically significant, all Fs < 3.59, p > .05. Post hoc comparisons confirmed that the 
group that received capsaicin alone (Veh-Cap) differed from the other groups for both 
ERK1 and ERK2, p < .05. No other group comparison was significant, p > .05.  
In the ventral region (Figure 13B), capsaicin induced an increase in ERK 
phosphorylation (pERK ratio) for both ERK1 and ERK2. Bicuculline pretreatment 
reduced the capsaicin induced elevation of ERK phosphorylation ratio in both ERK 
isoforms. For both ERK1 and ERK2, an ANOVA showed that the main effect of 
bicuculline and capsaicin, as well as their interaction, were statistically significant, all Fs 
> 8.13, p < .05. Post hoc comparisons confirmed that the group that received capsaicin 
alone (Veh-Cap) differed from the other groups for both ERK1 and ERK2, p < .05. No 
other group comparison was significant, p > .05. 
The results for other protein targets are depicted in Figures 14, 15, and 16. In 
the dorsal region, capsaicin and bicuculline treatment did not affect GAD65 and GAD67 
expression (Figure 14A), all Fs < 1.64, p > .05. In the ventral region (Figure 14B), 
bicuculline reduced GAD65 expression and capsaicin increased GAD67 expression. An 
ANOVA showed that the main effect of bicuculline treatment on GAD65, as well as the 
main effect of capsaicin treatment on GAD67 expression, was statistically significant, 
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both Fs > 5.62, p < .05. No other term was significant, all Fs < 2.55, p > .05. For 
GAD65, post hoc comparisons showed that the group that received capsaicin alone 
(Veh-Cap) differed from groups that received bicuculline (Bic-Veh, Bic-Cap), p < .05. 
For GAD67, the group that received capsaicin alone (Veh-Cap) differed from the groups 
that received capsaicin vehicle (Bic-Veh, Veh-Veh), p < .05. No other group comparison 
was significant, p > .05. 
For TrkB92 and TrkB145 within the dorsal region (Figure 15A), capsaicin 
treatment reduced expression in vehicle treated subjects, but enhanced expression in 
bicuculline treated rats, yielding a significant interaction, both Fs > 4.47, p < .05. No 
other term was statistically significant, all Fs < 3.8, p > .05. Post hoc comparison 
showed that the group that received bicuculline alone (Bic-Veh) differed from the sham 
group (Veh-Veh) for TrkB145, p < .05. No other group comparison was significant, p 
> .05. In the ventral region (Figure 15B), capsaicin induced an increase in TrkB92 
expression and bicuculline reduced TrkB145 expression. An ANOVA showed that the 
main effect of capsaicin treatment on TrkB92 expression, and the main effect of 
bicuculline treatment on TrkB145 expression, were statistically significant, both Fs > 
12.47, p < .05. No other term was significant, all Fs < 1.84, p > .05. For TrkB92, post 
hoc comparisons showed that the group that received capsaicin alone (Veh-Cap) differed 
from the groups that received capsaicin vehicle (Veh-Veh, Bic-Veh), p < .05. For 
TrkB145, the groups that received bicuculline (Bic-Veh, Bic-Cap) differed from the 
groups that did not receive bicuculline (Veh-Veh, Veh-Cap), p < .05. No other group 
comparison was significant, p > .05. 
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For CAMKII in the dorsal region (Figure 16A), neither capsaicin nor 
bicuculline treatment had a significant effect, all Fs < 2.77, p > .05. In the ventral region 
(Figure 16D), capsaicin induced a significant increase of CAMKII expression. An 
ANOVA showed that the main effect of capsaicin was statistically significant, F (1, 20) 
= 14.56, p < .05. No other term was significant, all Fs < 1.58, p > .05. Post hoc 
comparisons showed that the group that received capsaicin alone (Veh-Cap) differed 
from the groups that did not receive capsaicin (Veh-Veh, Bic-Veh), p < .05. No other 
group comparison was significant, p > .05. 
For BDNF in the dorsal region (Figure 16B), neither capsaicin nor bicuculline 
treatment had a significant effect, all Fs < 2.25, p > .05. In the ventral region (Figure 
16E), capsaicin induced an increase in BDNF expression. An ANOVA showed that the 
main effect of capsaicin was statistically significant, F (1, 20) = 7.01, p < .05. No other 
term was significant, all Fs < 1.29, p > .05. Post hoc comparisons showed that the group 
that received bicuculline alone (Bic-Veh) differed from the groups that received 
capsaicin (Veh-Cap, Bic-Cap), p < .05. No other group comparison was significant, p 
> .05. 
For TNFin the dorsal region (Figure 16C), neither capsaicin nor bicuculline 
had a significant effect, all Fs < 3.85, p > .05. In the ventral part (Figure 16F), capsaicin 
induced an increase in TNF expression. An ANOVA showed that the main effect of 
capsaicin was statistically significant, F (1, 20) = 46.04, p < .05. No other term was 
significant, all Fs < 2.4, p > .05. Post hoc comparisons showed that the groups that 
49 
 
received capsaicin (Veh-Cap, Bic-Cap) differed from the groups that received its vehicle 
(Veh-Veh, Bic-Veh) p < .05. No other group comparison was significant, p > .05. 
 
 
Figure 13. Protein expression of ERK, pERK and the pERK ratio after bicuculline and capsaicin treatment. 
(A) Expression in the dorsal region of the spinal cord. Bicuculline (Bic) and vehicle (Veh) treatment are 
shown on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are shown in black and 
white bars, respectively. ERK42 is shown in the upper part, and ERK44 is shown in the lower part of the 
panel. The y-axis depicts the fold change of protein expression for each group relative to the control (Veh-
Veh). (B) Protein expression in the ventral region of the spinal cord. The error bars depict ± SEM. 
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Figure 14. Protein expression of GAD65 and GAD67 after bicuculline and capsaicin treatment. (A) 
Expression in the dorsal region of the spinal cord. Bicuculline (Bic) or vehicle (Veh) treatment are shown 
on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are shown in black and white bars, 
respectively. GAD65 is shown in the left part, and GAD67 is shown in the right part of the figure. The y-
axis depicts the fold change of protein expression for each group relative to the control (Veh-Veh). (B) 
Protein expression level in the ventral region of the spinal cord. The error bars depict ± SEM. 
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Figure 15. Protein expression of Trk92 and Trk145 after bicuculline and capsaicin treatment. (A) 
Expression in the dorsal region of the spinal cord. Bicuculline (Bic) or vehicle (Veh) treatment are shown 
on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are shown in black and white bars, 
respectively. Trk92 is shown in the left part, and Trk145 is shown in the right part of the figure. The y-axis 
depicts the fold change of protein expression for each group relative to the control (Veh-Veh). (B) Protein 
expression level in the ventral region of the spinal cord. The error bars depict ± SEM. 
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Figure 16. Protein expression of CAMKII, BDNF, and TNF after bicuculline and capsaicin treatment in 
the dorsal (A-C) and ventral (D-F) tissue. (A and D) Protein expression level of CAMKII. Bicuculline (Bic) 
or vehicle (Veh) treatment are shown on the x-axis. Subjects that received capsaicin (Cap) or its vehicle 
(Veh) are shown in black and white bars, respectively. The y-axis depicts the fold change of protein 
expression for each group relative to the control (Veh-Veh). (B and E) Protein expression level of BDNF. 
(C and F) Protein expression level of TNF. The error bars depict ± SEM. 
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Discussion   
Capsaicin treatment increased expression of ERK, pERK, and pERK ratio in 
both dorsal and ventral region of the spinal cord. Bicuculline pretreatment was shown to 
attenuate the capsaicin-induced pERK ratio. These data provide further cellular evidence 
that bicuculline attenuates central sensitization in transected rats. For proteins involved 
in GABA synthesis, GAD65 and GAD67, bicuculline treatment reduced GAD65 
expression and capsaicin treatment increased GAD67 expression in the ventral region of 
the spinal cord. The unique distributions and expression patterns of GAD67 and GAD65 
suggest divergent functional roles of them. GAD67 predominates early in development 
and after neuronal injury and may subserve an intracellular GABA pool, whereas 
GAD65 is usually expressed later in development and is subject to regulation by cofactor 
binding and neuronal activity (Pinal & Tobin, 1998). The reduction of GAD65 in 
bicuculline treated rats presumably implies a decrease of GABAergic signaling, because 
bicuculline has already blocked central sensitization. The increase of GAD67 expression 
in capsaicin treated group could reflect the contributions of synaptogenesis and 
protection to capsaicin treatment.  
Bicuculline treatment was shown to reduce BDNF expression in both dorsal 
and ventral region. For the BDNF receptor protein, TrkB, capsaicin treatment showed a 
tendency to reduced expression of TrkB proteins in vehicle treated subjects, but 
enhanced expression in bicuculline treated subjects. Thus, bicuculline has a reducing 
effect on BDNF signaling, whereas capsaicin has the opposite effect － induces BDNF 
signaling. A possible explanation for the opposing effect of bicuculline and capsaicin on 
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BDNF signaling is that BDNF protects capsaicin-induced central sensitization. From this 
perspective, BDNF signaling is reduced in bicuculline treated subjects because central 
sensitization has already been blocked by bicuculline. In addition, capsaicin treatment 
enhanced CAMKII and TNF-alpha expression in the ventral region of the spinal cord. 
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CHAPTER V 
GABAAR ANTAGONIST’S EFFECT ON EMR IN SHAM-OPERATED INTACT 
RATS 
 
In Chapter III and IV, the results showed that the GABAA receptor plays a role 
in inflammation induced EMR and central sensitization. These data stand in contrast to 
work examining the effect of bicuculline treatment in intact rats, which has generally 
found that the drug induces EMR (Sorkin, Puig, & Jones, 1998; Zhang, Hefferan, & 
Loomis, 2001). These observations suggest that the same experimental manipulation 
may have opposite effects on capsaicin-induced EMR in intact and transected subjects. 
Here, I explore this possibility by testing the effect of bicuculline treatment on capsaicin-
induced EMR in intact (sham-operated) rats. 
 
Experiment 9 
 
I first accessed whether the GABAAR antagonist bicuculline enhances, rather 
than blocks capsaicin-induced EMR in intact rats. To facilitate comparison across 
experiments, all details (including surgery) were the same as Experiment 4, except the 
spinal cord was not transected. 
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Procedure 
The design of experiment 9 is similar to that used in Experiment 7 (see Figure 
1). The one change is that subjects received a sham surgery rather than transection. 
Immediately after the last behavior test, subjects (n=8 per group) were sacrificed.  
 Results 
Prior to treatment, mean baseline scores ranged from 5.97 ± 0.04 to 6.22 ± 0.08 
(mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 2.4, p > .05. 
The behavioral data are depicted in Figure 17. Before capsaicin treatment, 
bicuculline administration (Post Drug) had a significant effect on mechanical reactivity, 
F (1, 28) = 50.31, p > .05. Capsaicin and bicuculline treatment (Post Cap) both induced a 
lasting EMR (Bic-Veh, Veh-Cap). In addition, bicuculline treatment failed to block the 
capsaicin-induced EMR (Bic-Cap). An ANOVA showed that the main effect of 
bicuculline was significant, F (1, 28) = 34.6, p > .05. Also, the main effect of time, and 
its interaction with bicuculline and capsaicin were statistically significant, all Fs > 5.13, 
p < .05. Post hoc comparisons confirmed that the group that received capsaicin alone 
(Veh-Cap) differed from the other groups, p < .05. In addition, the vehicle treated group 
(Veh-Veh) differed from groups that received bicuculline (Bic-Veh, Bic-Cap), p < .05. 
No other group comparison was significant, p > .05. 
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Vehicle 
X 
Vehicle 
Bicuculline Capsaicin 
 
Figure 17. Bicuculline failed to block capsaicin-induced EMR in intact rats. Subjects that received 
bicuculline (Bic) and vehicle (Veh) are depicted as squares and circles, respectively. Groups treated with 
capsaicin (Cap) or its vehicle (Veh) are shown in black and white, respectively. The y-axis depicts the 
change from baseline after bicuculline treatment (Post Drug), and 0, 1, 2 hr after capsaicin treatment (Post 
Cap). The error bars depict ± SEM. 
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Discussion   
Bicuculline induced a lasting EMR, replicating previous results (Sorkin et al., 
1998; Zhang et al., 2001), and failed to block the capsaicin-induced EMR. These data 
imply that spinal injury alters GABAergic function and transforms how bicuculline 
affects capsaicin-induced EMR. 
 
Experiment 10 
 
Experiment 9 showed that bicuculline does not block capsaicin-induced EMR 
in intact subjects. In this experiment, I tested whether bicuculline treatment affects c-fos 
expression in uninjured rats using qRT-PCR. Again, c-jun was also assessed. 
Procedure 
Two hour after capsaicin treatment, subjects from Experiment 9 were 
sacrificed. A 1 centimeter of spinal cord around the lumbar enlargement (L3-L5) region 
was rapidly removed. These spinal cord samples were hemi-dissected into dorsal and 
ventral halves, and were then subjected to RNA extraction for qRT-PCR. 
 
Results 
The PCR results are depicted in Figure 18. The mRNA expression for each 
gene of interest was normalized to -actin expression level, and is presented as a fold 
change relative to the sham controls. In the dorsal region (Figure 18A), capsaicin 
induced an increase in c-fos mRNA expression level. Bicuculline pretreatment failed to 
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reduce the capsaicin induced elevation of c-fos level. An ANOVA revealed a significant 
main effect of capsaicin treatment, F (1, 20) = 6.33, p < .05. No other term was 
statistically significant, all Fs < 1.0, p > .05. Post hoc comparisons confirmed that the 
group that received bicuculline before capsaicin (Bic-Cap) differed from the other 
groups, p < .05. No other group comparison was significant, p > .05. In the ventral 
region (Figure 18B), neither capsaicin nor bicuculline treatment had a statistically 
significant effect on c-fos expression, all Fs < 1.17, p > .05.  
Neither capsaicin nor bicuculline treatment had a statistically significant effect 
on c-jun mRNA expression within the dorsal or ventral region (Figure 18A, 18B), all Fs 
< 1.0, p > .05. 
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Figure 18. c-fos and c-jun mRNA expression after bicuculline and capsaicin treatment in intact rats. (A) 
mRNA expression in the dorsal region of the spinal cord. Bicuculline (Bic) or vehicle (Veh) treatment are 
shown on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are shown in white and 
black bars, respectively. The y-axis depicts the fold change in mRNA expression relative to the control 
(Veh-Veh) (B) mRNA expression in the ventral region of the spinal cord. The error bars depict ± SEM. 
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Discussion   
In contrast to Experiment 7, which showed bicuculline attenuate capsaicin-
induced c-fos expression in transected rats, drug treatment had no effect in intact rats. 
 
Experiment 11 
 
Experiment 10 showed that bicuculline does not attenuate capsaicin-induced c-
fos mRNA expression level within the dorsal horn in intact rats. Here I examine another 
cellular marker of central sensitization, phosphorylate on ERK (pERK) protein. 
Procedure 
After RNA extraction in Experiment 10, total protein was extracted from the 
organic layer of the 48 samples (24 dorsal, 24 ventral), and was used for Western 
Blotting. The protein expression for each target was normalized to -actin expression 
level, and was presented as a fold change in experimental groups relative to the sham 
controls. Subsequently, the protein expression of pERK1/2 was normalized to ERK1/2 
expression yielding a pERK/ERK ratio. 
 Results 
ERK protein levels are depicted in Figure 19. In the dorsal region (Figure 19A), 
bicuculline and capsaicin treatment both induced an elevation in ERK1 (ERK44) and 
ERK2 (ERK42), all Fs > 4.55, p < .05. Post hoc comparisons confirmed that the vehicle- 
treated (Veh-Veh) group differed from the other groups in ERK1, p < .05. For ERK2, 
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the vehicle-treated group (Veh-Veh) differed from the groups that received bicuculline 
(Bic-Veh, Bic-Cap), p < .05. No other group comparison was significant, p > .05. For 
pERK, capsaicin induced an elevation in both pERK1 and pERK2, both Fs > 9.04, p 
< .05. Post hoc comparisons confirmed that the groups that received bicuculline before 
capsaicin (Bic-Cap) differed from the groups that received capsaicin vehicle (Veh-Veh, 
Bic-Veh) in pERK1. In addition, the vehicle treated group (Veh-Veh) differed from the 
groups that received capsaicin (Veh-Cap, Bic-Cap) in pERK2, p < .05. No other group 
comparison was significant, p > .05. For pERK ratio, neither capsaicin nor bicuculline 
had statistically significant effect on ERK phosphorylation for ERK1 or ERK2, all Fs < 
2.98, p > .05.  
In the ventral region (Figure 19B), neither bicuculline nor capsaicin had 
significant effect on ERK and pERK expression for both isoforms, all Fs < 2.65, p > .05. 
For pERK ratio, capsaicin induced an increase in ERK phosphorylation in ERK1. 
Bicuculline pretreatment failed to reduce the capsaicin induced elevation of ERK 
phosphorylation ratio. An ANOVA showed that the main effect of capsaicin was 
statistically significant, F (1, 20) = 6.48, p < .05. No other term was statistically 
significant, all Fs < 3.38, p > .05. Post hoc comparisons showed that the group that 
received bicuculline before capsaicin treatment (Bic-Cap) differed from the group that 
received bicuculline alone (Bic-Veh) in ERK1, p < .05. No other group comparison was 
significant, p > .05. 
In addition, the overall expression of ERK and pERK protein in dorsal region 
of the spinal cord in intact and transected rats was examined. A comparison of the results 
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(Figure 13 versus Figure 19) suggests that spinal transection increased the expression of 
ERK and pERK protein. An ANOVA showed that the main effect of transection was 
statistically significant for both ERK and pERK, all Fs > 4.74, p < .05. 
 
 
Figure 19. Protein expression of ERK, pERK, and the pERK ratio after bicuculline and capsaicin 
treatment in intact rats. (A) Expression in the dorsal region of the spinal cord. Bicuculline (Bic) or vehicle 
(Veh) treatment are shown on the x-axis. Subjects that received capsaicin (Cap) or its vehicle (Veh) are 
shown in black and white bars, respectively. ERK42 is shown in the upper part, and ERK44 is shown in 
the lower part of the figure. The y-axis depicts the fold change of protein expression for each group 
relative to the control (Veh-Veh). (B) Protein expression in the ventral region of the spinal cord. The error 
bars depict ± SEM. 
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Discussion   
I found that capsaicin induced ERK and pERK expression in the dorsal horn 
and that the effect was not blocked by bicuculline. These data provide further cellular 
evidence that bicuculline pretreatment fails to block central sensitization in intact 
subjects. Comparing these results to those obtained in transected rats (Experiment 8), it 
appears that the impact of bicuculline on capsaicin-induced central sensitization depends 
on the integrity of spinal circuits － that a spinal transection switches GABAergic 
function. Further, the protein expression level changes of transected rats are much larger 
than those of intact rats, suggesting that descending system normally inhibits the 
development of central sensitization. 
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CHAPTER VI 
SPINAL TRANSECTION SWITCHES GABA FROM INHIBITORY TO 
EXCITATORY 
 
Results from Chaper IV and V showed that blocking the GABAA receptor 
yields opposite effects in spinally transected and intact rats. This alternation in 
GABAergic function may be due to an injury-induced change in cation-chloride 
cotransporters. The chloride gradient in the neural membrane is critically important to 
GABAA receptor mediated inhibitory function because the GABAA receptor is anion-
permeable (Kaila, 1994). Na+-K+-Cl− cotransporter 1 (NKCC1) and K+-Cl− cotransporter 
2 (KCC2) are the two chloride transporters that regulate the intracellular chloride 
concentration ([Cl−]intra). NKCC1 transports the Cl- into the cell and KCC2 transports the 
Cl- out of cell into the extracellular space. Research has shown that SCI upregulates 
NKCC1 whereas KCC2 is downregulated in the spinal cord, which correlates with 
allodynia and hyperalgesia (Cramer et al., 2008; Hasbargen et al., 2010). The 
upregulation of NKCC1 and downregulation of KCC2 produce high [Cl−]intra that 
facilitates efflux of Cl− when the GABAA receptor is activated, which leads to 
depolarization (excitatory) rather than hyperpolarization (inhibitory). This GABAAR-
mediated membrane depolarizations can cause activation of cation channels, such as 
voltage-dependent Na+ and Ca2+ channels that generate excitation of neurons, and lead to 
the enhanced nociceptive transmission, rather than inhibition after SCI.  Here I examine 
whether spinal injury affects KCC2 membrane-bound levels and whether a change in 
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channel function can explain why bicuculline treatment has opposite effects in injured 
and intact rats. 
 
Experiment 12 
 
Previous work suggests that spinal transection transforms the action of GABA, 
causing it to have an excitatory effect. This biological switch of GABA from inhibitory 
to excitatory may be due to the down-regulation of membrane-bound KCC2 and loss of 
descending control from the brain (Ben-Ari, 2002; Bos et al., 2013; Boulenguez et al., 
2010). To investigate whether the opposing effect of GABAA receptor blockage in the 
transected and intact rats is due to a change in KCC2 protein expression, I evaluated 
KCC2 protein expression levels using Western Blotting. 
Procedure 
The design of experiment 12 is depicted in Figure 20. Twelve rats were 
randomly assigned to receive a spinal transection at T2 or sham-operation. Baseline 
behavioral reactivity was tested using von Frey stimuli 24 hr later. Subjects were then 
sacrificed and a one-centimeter section of the spinal cord containing the lumbar 
enlargement (L5-L6) region was rapidly removed. These spinal cord samples were hemi-
dissected into dorsal and ventral halves, and then went through homogenization, protein 
extraction, and fractionation (membrane-bound and cytoplasmic fraction) for Western 
Blotting. KCC2 protein expression was normalized to -actin expression level, and was 
presented as a fold change in the transected group relative to the sham group. 
67 
 
Subsequently, the protein expression of membrane-bound fraction was normalized to the 
cytoplasmic fraction yielding a membrane-bound/cytoplasmic ratio. 
 
Complete 
transection (T2) 
24 hr 
von Frey 
Baseline 
Tissue 
collection 
Sham operated 
Figure 20. Experimental design for Experiment 12. 
 
Results 
The behavioral data are depicted in Figure 21. Intact rats were more responsive 
than spinally transected subjects. An ANOVA revealed a significant main effect of 
transection, F (1, 10) = 18.34, p < .05. 
KCC2 protein expression levels are depicted for the membrane-bound and 
cytoplasmic fractions (Figure 22A and B). Transection induced a reduction in 
membrane-bound KCC2 and an increase in cytoplasmic KCC2. An ANOVA showed 
that the main effect of fraction, and its interaction with transection, were statistically 
significant, both Fs > 10.75, p < .05. Post hoc comparisons showed that the cytoplasmic 
fraction of transected rats differed from intact subjects, p < .05. No other group 
comparisons were significant, p > .05. 
For the membrane-bound/cytoplasmic ratio (Figure 22C), transection induced a 
46% reduction in KCC2 protein expression. An ANOVA revealed a revealed a 
significant main effect of transection, F (1, 10) = 9.31, p < .05. 
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Figure 21. Baseline tactile reactivity for intact and transected rats. The y-axis depicts the linearized tactile 
scores of baseline. The error bars depict ± SEM. 
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Figure 22. Transection induced a decrease of membrane-bound KCC2 expression. (A) KCC2 in the 
cytoplasmic fraction. (B) KCC2 in the membrane-bound fraction. (C) The fold change of membrane-
bound/cytoplasmic ratio. The error bars depict ± SEM. 
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Discussion   
I found that a spinal transection enhanced tactile reactivity relative to intact rats. 
This may be due to the lack of descending inhibition from the brain. I also found that 
transection increased the cytoplasmic KCC2 and decreased the membrane-bound form. 
This suggests that a reduction in the membrane-bound KCC2 transporter, through 
internalization, underlies the alternation in GABA function observed after transection. 
 
Experiment 13 
 
The results of Experiment 12 imply that a transection-induced reduction in 
membrane-bound KCC2 underlies a biological switch that alters how GABAA receptor 
blockade affects capsaicin-induced EMR (Experiment 4 and 7). KCC2 plays a critical 
role in controlling [Cl−]intra, which determines whether GABA is inhibitory or excitatory. 
Given this, pharmacologically blocking the KCC2 channel in intact rats should emulate 
the effect of spinally-transection and switch how bicuculline treatment affects capsaicin-
induced EMR. Here, I test whether the KCC2 blocker DIOA induces an injury-like state 
wherein bicuculline has an anti-allodynic effect. 
Procedure 
The design of experiment 13 is depicted in Figure 23. Sham operated (with 
intact spinal cord) and cannulized rats (n=8 per group) were microinjected with either 
vehicle or 20 ug DIOA (i.t.). Fifteen minutes after drug delivery, subjects in each group 
received either the vehicle (saline) or bicuculline (i.t.). Fifteen minutes after drug 
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delivery, subjects in each group received an intradermal injection of capsaicin on one 
hindlimb (balanced across subjects). This yielded a 2 (DIOA vs. vehicle) X 2 
(bicuculline vs. vehicle) factorial design. Tactile reactivity was assessed on each paw 
prior to drug delivery (baseline), post drug treatment, and again 0, 1, 2, 3 hr following 
capsaicin treatment. A change from baseline score was calculated to assess the impact of 
the experimental manipulations. 
 
Figure 23. Experimental design for Experiment 13. 
 
Results 
Prior to drug manipulations, mean baseline scores ranged from 5.63 ± 0.08 to 
5.76 ± 0.05 (mean ± standard error of the mean [SE]) across groups. These differences 
were not statistically significant, all Fs < 1.08, p > .05.  
The effect of bicuculline on capsaicin-induced EMR after DIOA treatment is 
depicted in Figure 24. Before bicuculline treatment, DIOA administration (Post Drug) 
increased mechanical reactivity. An ANOVA revealed a significant effect of DIOA 
treatment, F (3, 28) = 7.79, p < .05. Before capsaicin treatment, bicuculline per se (Veh-
Bic) induced EMR, which replicates the result of Experiment 9. An ANOVA showed 
that the main effect of DIOA and bicuculline, as well as their interaction, were 
statistically significant, all Fs > 6.16, p < .05. Post hoc comparisons confirmed that the 
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group that received bicuculline alone (Veh-Bic) differed from the other groups, p < .05. 
No other group comparison was significant, p > .05. 
Capsaicin treatment (Post Cap) induced a lasting EMR (Veh-Veh). This effect 
was blocked by pretreatment with DIOA and bicuculline (DIOA-Bic). Replicating 
Experiment 9, bicuculline treatment failed to block capsaicin-induced EMR without 
DIOA treatment (Veh-Bic). An ANOVA showed that the main effect of DIOA and 
bicuculline, as well as their interaction, were statistically significant, all Fs > 23.9, p 
< .05. Also, the main effect of time, and its interaction with bicuculline, were 
statistically significant, both Fs > 6.9, p < .05.  No other term was significant, all Fs < 
2.53, p > .05. Post hoc comparisons confirmed that the group that received DIOA and 
bicuculline (DIOA-Bic) differed from the other groups, p < .05. In addition, the group 
that received DIOA alone (DIOA-Veh) differed from the group that received bicuculline 
alone (Veh-Bic). No other group comparison was significant, p > .05. 
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Figure 24. Bicuculline blocked capsaicin-induced EMR in intact rats after DIOA treatment. Subjects that 
received DIOA and its vehicle (Veh) are shown in black and white, respectively. Groups given bicuculline 
(Bic) or its vehicle (Veh) are depicted as squares and circles, respectively. The y-axis depicts the change 
from baseline after DIOA and bicuculline treatment (Post Drug), and 0, 1, 2, 3 hr after capsaicin treatment 
(Post Cap). The error bars depict ± SEM. 
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Discussion  
DIOA reduced mechanical reactivity and blocked the allodynia inducing effect 
of bicuculline. Also, bicuculline blocked the capsaicin-induced EMR in DIOA treated 
intact rats. Comparing the results to those obtained in Experiments 4 and 9, it appears 
that DIOA treatment induced a state that emulated the effect of spinal transection, 
eliminating the EMR induced by bicuculline and flipping the effect of bicuculline on 
capsaicin-induced EMR. This change of GABA effect is presumably due to an increase 
in [Cl−]intra. 
 
Experiment 14 
 
The effect of GABA (inhibitory or excitatory) depends on intracellular chloride 
concentrations. This is regulated by both KCC2 and NKCC1. Prior work has shown that 
the effect of decreased KCC2 on intracellular chloride gradient can be countered by 
blocking the inward flow of chloride using a NKCC1 antagonist (Cramer et al., 2008; 
Hasbargen et al., 2010). This suggests that administration of a NKCC1 antagonist 
(bumetanide) could reinstate inhibitory GABAergic tone in transected rats. Given this, I 
examined whether bumetanide treatment could switch the effect of bicuculline, causing 
it to enhance capsaicin-induced EMR in spinally-transected rats. 
Procedure 
The design of Experiment 14 is depicted in Figure 25. Spinally-transected and 
cannulized rats (n=8 per group) were microinjected with either vehicle or 1mM 
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bumetanide (BUM; i.t.). Fifteen minutes after drug delivery, subjects in each group 
received either the vehicle (saline) or bicuculline (i.t.). Fifteen minutes after drug 
delivery, subjects in each group received an intradermal injection of capsaicin on one 
hindlimb (balanced across subjects). This yields a 2 (bumetanide vs. vehicle) X 2 
(bicuculline vs. vehicle) factorial design. Tactile reactivity was assessed on each paw 
prior to drug delivery (baseline), post drug treatment, and again 0, 1, 2, 3 hr following 
capsaicin treatment. A change from baseline score was calculated to assess the impact of 
the experimental manipulations. 
 
Figure 25. Experimental design for Experiment 14. 
 
Results 
Prior to drug treatment, mean baseline scores ranged from 6.0 ± 0.03 to 6.16 ± 
0.08 (mean ± standard error of the mean [SE]) across groups. These differences were not 
statistically significant, all Fs < 2.22, p > .05.  
The effect of bicuculline on capsaicin-induced EMR after BUM treatment is 
depicted in Figure 26. Before bicuculline treatment, BUM administration (Post Drug) 
had no effect on mechanical reactivity, F (3, 20) = 1.22, p > .05. Before capsaicin 
treatment, bicuculline induced EMR in BUM treated subjects (BUM-Bic). An ANOVA 
showed that the interaction of BUM and bicuculline was statistically significant, F (1, 20) 
= 4.68, p < .05. No other term was significant, all Fs < 3.58, p > .05. Post hoc 
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comparisons confirmed that the group that received BUM and bicuculline (BUM-Bic) 
differed from the other groups, p < .05. No other group comparison was significant, p 
> .05. 
Capsaicin treatment (Post Cap) induced a lasting EMR (Veh-Veh, BUM-Veh). 
This effect was blocked by pretreatment with bicuculline alone (Veh-Bic). Bicuculline 
treatment failed to block capsaicin-induced EMR in BUM treated subjects (BUM-Bic). 
An ANOVA showed that the main effect of BUM and bicuculline, as well as their 
interaction, were statistically significant, all Fs > 5.2, p < .05. Also, the main effect of 
time and its interaction with BUM and bicuculline, as well as the time x BUM x 
bicuculline three way interaction, were significant, all Fs > 2.97, p < .05.  Post hoc 
comparisons confirmed that the group that received bicuculline alone (Veh-Bic) differed 
from the other groups, p < .05. No other group comparison was significant, p > .05. 
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Figure 26. Bicuculline failed to block capsaicin-induced EMR in transected rats after BUM treatment. 
Subjects that received BUM or its vehicle (Veh) are shown in black and white, respectively. Groups given 
bicuculline (Bic) or its vehicle (Veh) administration are depicted as squares and circles, respectively. The 
y-axis depicts the change from baseline after BUM and bicuculline treatment (Post Drug), and 0, 1, 2, 3 hr 
after capsaicin treatment (Post Cap). The error bars depict ± SEM. 
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Discussion  
After bumetanide treatment, the allodynia inducing effect of bicuculline was 
reinstated. As in Experiment 4, bicuculline alone blocked capsaicin-induced EMR. 
Pretreatment with bumetanide eliminated this effect. Thus, blocking NKCC1 channel 
with bumetanide in transected rats emulated the pattern of results observed in intact rats 
(Experiment 9), producing a state wherein blocking the GABAA receptor induces EMR 
and fails to attenuate capsaicin-induced EMR. Together with Experiment 13, these data 
suggest that spinal injury modifies GABAergic function by inducing a change in 
[Cl−]intra. 
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CHAPTER VII 
GENERAL DISCUSSION AND SUMMARY 
 
 
 
Prior studies have shown that pathological conditions can induce a lasting 
increase in nociceptive excitation within the CNS (central sensitization; Ji et al., 2003; 
Woolf, 2004). A variety of events, including VIS, LPS, and peripheral inflammation, 
have been shown to induce EMR, which is linked to a NMDAR-mediated sensitization 
of spinal neurons (Baumbauer et al., 2008; Baumbauer et al., 2012; Hook et al., 2008; 
Reeve et al., 2000). In addition to the NMDAR-mediated signaling, malfunctioning of 
GABAergic system has been suggested to contribute to central sensitization (Gwak & 
Hulsebosch, 2011). Prior works from out laboratory has shown that treatments (VIS and 
LPS) that induce central sensitization impair spinal learning (Ferguson, Crown, & Grau, 
2006; Ferguson et al., 2003; Young et al., 2007). It has also been observed that the 
inhibitory effect VIS has on learning is blocked by bicuculline, a GABAA receptor 
antagonist (Ferguson et al., 2003). This leads to the prediction that GABA may be 
excitatory after SCI, and bicuculline treatment may also block the VIS-induced EMR. 
Indirect support for this comes from studies showing that GABA can have an excitatory 
effect in other conditions (Ben-Ari, 2002; Ge et al., 2006; Gulledge & Stuart, 2003; 
Marty & Llano, 2005). These findings suggest that GABA effect can switch from 
inhibitory to excitatory after SCI, and thereby contribute to the emergence of central 
sensitization. 
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The present dissertation examines a number of questions raised by prior studies: 
first, would bicuculline block VIS-induced and inflammation-induced EMR in 
transected subjects (LPS and capsaicin); second, does blocking GABA function have 
opposite effects in intact rat versus spinally-transected subject; third, does SCI alter the 
role of GABA by modifying membrane concentration of the proteins that regulate 
intracellular Cl- concentration? 
I first established whether bicuculline administration blocks the shock (VIS) 
induced EMR (Experiment 1). I found that VIS induced a lasting EMR, which replicates 
the previous findings (Ferguson et al., 2000; 2001). This effect was blocked by 
pretreatment with the GABAA antagonist bicuculline.  
To explore the generality of this effect, I tested whether bicuculline treatment 
would block LPS-induced EMR (Experiment 2). LPS has been shown to induce both 
EMR and a spinally-mediated learning impairment (Reeve et al., 2000; Vichaya et al., 
2009; Young et al., 2007). I found that bicuculline pretreatment blocks LPS induced 
EMR. For the maintenance of LPS induced EMR, I found that bicuculline failed to 
reverse it (Experiment 3). 
Experiments 1, 2, and 3 showed that spinal GABAA receptor transmission is a 
crucial component of signaling cascade for enhanced mechanical reactivity and suggest a 
role in central sensitization. The next two experiments (Experiment 4 and 5) provide a 
more direct test of this hypothesis by examining the impact of peripheral treatment with 
the irritant capsaicin. Capsaicin has been shown to induce central sensitization, as well 
as the concomitant EMR and learning deficit (Hook et al., 2008; Woolf, 2011). I found 
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that bicuculline pretreatment blocked the induction (Experiment 4) and maintenance 
(Experiment 5) of capsaicin-induced EMR. Further, the nociceptive agent capsaicin 
applied to one hind leg induced EMR on both the ipsilateral and contralateral legs, 
implying an increase in the excitability and synaptic efficacy of neurons in central 
nociceptive pathways. This effect suggests a heterosynaptic potentiation and implicates 
central sensitization (Woolf & Salter, 2000). Hence, the data suggest that bicuculline 
treatment is capable of blocking and reversing the capsaicin induced central sensitization. 
Experiment 6 provided a more detailed analysis of the role of GABA in 
capsaicin-induced EMR. At issue is whether bicuculline blocked capsaicin-induced 
EMR through GABAA receptor rather than Ca2+ activated potassium channels 
(Khawaled et al., 1999). To address this issue, subjects were given another GABAA 
receptor antagonist, gabazine. As expected, gabazine pretreatment blocked capsaicin-
induced EMR (Experiment 6A). I also assessed the effect of the GABAB receptor 
antagonist, phaclofen (Experiment 6B). Surprisingly, phaclofen pretreatment blocked the 
capsaicin-induced EMR, though it appeared to be less effective than gabazine. 
Experiments 4-6 provide behavioral evidence that the GABAergic system is 
involved in the sensitization of nociceptive processes (central sensitization). Next, I 
examined the impact of bicuculline treatment on cellular indices (mRNA and protein) of 
nociceptive sensitization. PCR and western blotting (Experiment 7 and 8 respectively) 
showed that capsaicin induced c-fos and pERK expression in the dorsal horn and that 
these effects were reduced by bicuculline pretreatment. Although capsaicin induced c-fos 
expression within the ventral horn was not affected by bicuculline pretreatment, pERK 
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protein expression showed a pattern similar to that observed in the dorsal horn. There 
was no significant change in GAD65 and 67 in dorsal horn which suggests that the effect 
of bicuculline depends on GABA receptors rather than GABA synthesis. Bicuculline 
treatment did reduce BDNF expression in both dorsal and ventral region. For the BDNF 
receptor protein, TrkB, capsaicin treatment reduced expression in vehicle treated 
subjects, but enhanced expression in bicuculline treated subjects. There was a trend 
towards higher BDNF expression in capsaicin treated subjects, which agrees with prior 
work showing that capsaicin induces a dose-dependent release of BDNF (Lever et al., 
2001). This may suggest that capsaicin induces BDNF signaling, whereas bicuculline 
blocks it. A possible explanation is that BDNF has a protective effect on capsaicin-
induced central sensitization. This BDNF-dependent mechanism may not be engaged in 
bicuculline treated subjects, because central sensitization has already been blocked. 
Results from Experiments 4 to 8 imply that pretreatment with the GABAA 
receptor antagonist bicuculline blocks capsaicin-induced central sensitization in spinally 
transected rats, implying that GABA is excitatory. This stands in contrast to previous 
work examining the effect of bicuculline treatment in intact rats, which has generally 
found that the drug induces EMR (Sorkin et al., 1998; Zhang et al., 2001). Given this 
discrepancy, Experiments 9 to 11 explored the impact of my experimental manipulations 
in intact (sham operated) subjects. Pretreatment of bicuculline per se induced EMR 
(allodynia) in intact rats and failed to block the capsaicin induced EMR. Likewise, 
bicuculline pretreatment failed to block cellular indices of central sensitization in the 
dorsal horn. Comparing these results to those observed in transected rats (Experiment 7 
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& 8), bicuculline pretreatment showed the opposite effect on capsaicin-induced central 
sensitization in intact subjects. This implies that spinal injury switches how GABA 
affects nociceptive systems. Further, cellular indices of central sensitization are higher in 
transected rats. The loss of descending inhibition from the brain in transected rats is the 
probable cause of this difference. 
In the process of examining how spinal injury affects GABAergic system, 
Experiment 12 revealed that spinal transection per se increases mechanical reactivity 
threshold. This may indicate that, in intact rats, the withdrawal response is partially 
mediated (facilitated) by brain-dependent systems. Alternatively, the PNS may down-
regulate nociceptive signaling after spinal injury to compensate for the centrally-
mediated hyperexcitability that emerges after the loss of descending inhibition. Also, as 
previously reported (Boulenguez et al., 2010), spinal transection reduced membrane-
bound KCC2 expression. This downregulation of KCC2 is thought to depend on a PKC-
dependent pathway (Lee, Deeb, Walker, Davies, & Moss, 2011). These data suggest that 
spinal transection induces downregulation of membrane-bound KCC2, which results in 
the high [Cl-]intra, and GABA-mediated depolarization. 
To further confirm that [Cl-]intra underlies the alteration in GABA function, 
Experiments 13 and 14 tested whether drug manipulations that target the [Cl-]intra 
controlling cotransporters, NKCC1 and KCC2, affect how GABAA receptor blockage 
impact nociceptive sensitization. Results showed that blocking KCC2 in intact rats is 
capable of emulating the blocking effect of bicuculline on capsaicin-induced EMR in 
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transected rats. Conversely, blocking NKCC1 in transected rats emulates the EMR-
inducing effect of bicuculline in intact rats. 
Taken together with previous findings (Boulenguez et al., 2010; Cramer et al., 
2008; Hasbargen et al., 2010), this dissertation revealed that GABA shows excitatory 
effect after SCI, relative to the inhibitory effect in intact subjects. This biological switch 
in GABAergic mechanism results from the expressional change of KCC2 cotransporter, 
which controls the intracellular chloride concentration, through a PKC dependent 
pathway (Lee et al., 2011). 
 
Role of GABA in SCI 
 
GABA is the main inhibitory neurotransmitter in the nervous system, and was 
further divided into two modes of neuronal inhibition- phasic and tonic (Farrant & 
Nusser, 2005). It has been suggested that neurons are not the only type of cell that 
synthesizes GABA; glia cells have also been shown to synthesize GABA (Velez-Fort, 
Audinat, & Angulo, 2012). Interaction between neurons and glia synergistically control 
inhibitory system functioning. After spinal cord injury, hyperexcitable neurons and glial 
activation disrupts the balance of chloride ions, glutamate and GABA distribution in the 
spinal dorsal horn and results in chronic neuropathic pain (Gwak & Hulsebosch, 2011). 
In short, SCI activate both ionotropic and metabotropic glutamate receptors on astrocyte 
and microglia. This activation leads to the subsequent membrane depolarization that 
triggers increased influx of Na+ and Ca2+ ions into both neurons and glia. Subsequently, 
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the elevated Ca2+ concentrations in astrocytes and microglia initiate the activation of 
mitogen-activated protein kinase (MAPK, p38-MAPK and ERK) and phospholipase 
(PLA2) that result in the modulation of target protein expression or phosphorylation of 
membrane receptor and ion channels through activation of transcription factors. The 
activated glial cells release glutamate, ATP, proinflammatory cytokines, prostaglandins 
(PGs), reactive oxygen (ROS) and nitrogen species (NOS) into the extracellular space (Ji 
et al., 2003). These pain mediating substances that are released by activated glia 
contribute to intracellular downstream biochemical pathways and provide an 
intracellular feed forward mechanism for continued activation (phosphorylation) of 
receptors and ion channels. In concomitant with the excitatory GABA and glycine, this 
mechanism ensures the induction and maintenance of the central neuronal 
hyperexcitability. 
Hypofunction or malfunction of GABAergic inhibition is one of the most 
important factors in the enhanced synaptic transmission and may underlie neuronal 
hyperexcitability in dorsal horn neurons following spinal cord injury. A hypothetical 
model is shown in Figure 27. Under normal conditions, phasic GABA release allows the 
rapid and precise modulation of pre- and post-synaptic signaling at the synaptic site, 
whereas tonic GABA increases the input conductance persistently through extrasynaptic 
receptors. The low [Cl-]intra caused by NKCC1 and KCC2 endows the hyperpolarizing 
effect of GABA in both CNS and PNS. After SCI, especially during the acute phase of 
spinal transection, the loss of descending inhibition from the brain leads to a hyper-
excited state within the spinal cord. The loss of descending projections (serotonin) from 
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the brain cause the down-regulation of KCC2 and the subsequent increase in [Cl-]intra 
(Bos et al., 2013; Boulenguez et al., 2010). Synergy of SCI-induced hyperexcitable 
neurons and glial activation disrupts the normal physiological homeostasis, and underlies 
the depolarizing GABA in the CNS. Research has shown that neurons can tune 
themselves to maintain levels of excitation by modulating different ion channels 
(Grashow, Brookings, & Marder, 2010; Rush et al., 2006; Waxman, Cummins, Dib-Hajj, 
Fjell, & Black, 1999). In the hyperexcited CNS, firing properties of dorsal root ganglion 
(DRG) neurons (PNS) may decrease by altering sodium channel expression. By 
changing the excitability of primary afferent sensory neurons, this lowers the input 
conductance of the PNS and is able to protect the CNS from excitotoxicity. This could 
also explain the higher mechanical reactivity of the transected rats (see Figure 21, 
Experiment 12) and the DIOA treated intact rats (see Figure 23, Experiment 13). 
Malfunctioning of GABA has been suggested to be the underlying mechanism of 
neuropathic pain (Gwak & Hulsebosch, 2011), such as inflammation induced 
neuropathic pain (Sluka et al., 1993, 1994) and spontaneous pain in diabetes (Jolivalt et 
al., 2008). Similar to my result, the blocking effect of GABAA receptor antagonist on 
neuropathic pain mentioned above has also been shown. This drug effect on nociceptive 
activation is attributed to KCC2 depletion within the CNS which then underlies the 
malfunction of GABA and the following central sensitization. Further, Reichl et al. 
(2012) showed that intrathecal but not peripheral administration of muscimol (GABAA 
receptor agonist) and baclofen (GABAB receptor agonist) reduced mechanical and 
thermal hyperalgesia after plantar incision in rats. It seems that the GABA functioning 
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within the CNS is the major factor that determines the homeostasis of nociceptive 
plasticity, and GABA can be either hyperpolarizaing or depolarizaing depending on the 
[Cl-]intra. From this view, CNS works as a shunt and PNS acts as a receiver and 
conductor. 
GABA-dependent depolarization has also been linked to the dorsal root reflex 
(DDR) triggered by primary afferent depolarization (PAD). The GABAergic input is 
normally inhibitory and mediates presynaptic inhibition. It can, however, have an 
excitatory effect when DRR is triggered. Inflammatory stimuli activate NKCC1 within 
the DRG. This leads to an increase in intracellular Cl- within the afferent neuron, which 
cause GABAergic input to have an excitatory effect (Delpire & Austin, 2010; Pitcher & 
Cervero, 2010). In the presence of inflammation, engaging the GABAA receptor on the 
primary afferent terminal causes an efflux of chloride ions, inducing depolarization in 
the primary afferent (Cervero & Laird, 1996; Rudomin & Schmidt, 1999; Willis, 1999). 
As a result, GABA release can increase nociceptive input and enhance pain reactivity. 
PAD and DRR have been suggested to contribute to inflammation-induced 
hyperalgesia and the accompanying flare, swelling, and increased temperature. These 
symptoms are unilateral, limited to the affected region (Lin, Wu, & Willis, 1999; Sluka 
et al., 1993, 1994; Willis, 1999). Evidence that these changes have a functional role rises 
from studies demonstrating that pretreatment with bicuculline reduces inflammation-
induced flare and hyperalgesia (Lin et al., 1999; Sluka et al., 1993, 1994). Because this 
could also reduce capsaicin-induced EMR, it is possible that the DRR and PAD 
contribute to the effects I reported. However, the contribution of this effect would be 
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limited to the treated dermatone; PAD and DRR could not explain the effect of 
bicuculline treatment on the EMR observed on the contralateral leg. Nor could it explain 
the effect of bicuculline on LPS-induced EMR. Finally, I examined whether i.t. 
treatment with bicuculline affects capsaicin-induced swelling and paw temperature. 
Drug treatment did not have a significant effect. These observations suggest that the 
GABAergic mechanism studied within my dissertation modulates nociceptive processes 
in a general fashion. 
 
Yin-yang of GABAergic system 
 
Like Yin-yang, everything is relative and nothing is absolute, GABA can be 
either excitatory or inhibitory depending on different circumstances. As discussed above, 
it is clear that GABA can have bidirectional effect, leading to inhibition in intact rats and 
excitation in spinally transected rats. The GABAA receptor, an ionotropic channel 
receptor, seems to play a major role in mediating this switch, through KCC2 
expressional change and the following turnover of intracellular chloride concentration. 
However, GABAB receptor has also been shown to play a role. Experiment 6 showed 
that phaclofen, a GABAB receptor antagonist, blocked capsaicin-induced EMR, which 
implies that the GABAB receptor also contributes to the excitatory effect of GABA, 
though less effective. This difference of effectiveness is presumably linked to the 
characteristic difference between GABAA and GABAB receptor, which are ionotropic 
and metabotropic, respectively. Similar to my result, Hirono et al. (2001) have also 
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shown that postsynaptic GABAB receptor can contribute GABA-dependent excitation by 
interacting with mGluR1. This has been shown to enhance mGluR1 mediated excitatory 
transmission at cerebellar parallelfiber-Purkinje cell excitatory synapses. In addition, 
VIS has been shown to induce both a spinally-mediated learning deficit (Ferguson et al., 
2003) and EMR (Ferguson et al., 2001; Experiment 1). Activation of mGluR1 was found 
to be both necessary and sufficient for this metaplastic inhibition of spinal learning 
(Ferguson et al., 2008). These findings suggest that the GABAB receptor contributes to 
the excitatory effect of GABA through its interaction with mGluR1. Taken together, my 
results suggest that both GABAA and GABAB receptor contribute to the excitatory effect 
of GABA after spinal injury. 
Descending Input from the Brain 
Descending control of spinal nociception originates from many brain regions and 
plays a critical role in determining the experience of both acute and chronic pain. The 
periaqueductal gray matter (PAG), the nucleus raphe magnus and adjacent structures of 
the rostral ventromedial medulla (RVM), send projections to the spinal dorsal horn. Prior 
research suggests that supraspinal systems can have a dual action, facilitating or 
inhibiting nocicpetive transmission (Dogrul, Ossipov, & Porreca, 2009; Suzuki & 
Dickenson, 2005; Suzuki, Rygh, & Dickenson, 2004). As in models of inflammation 
(Millan, 2002), descending inhibition generally predominates over descending 
facilitation in the primary pain circuits with input from the inflamed tissue; while in the 
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secondary pain circuit, descending facilitation predominates over descending inhibition 
with input from neighboring tissues. Also, the inhibitory descending control from the 
PAG-RVM system preferentially suppresses nociceptive inputs mediated by C-fibers, 
preserving sensory-discriminative information conveyed by more rapidly conducting A-
fibers (Heinricher, Tavares, Leith, & Lumb, 2009; Suzuki & Dickenson, 2005; Suzuki et 
al., 2004; Vanegas & Schaible, 2004). Different 5-HT receptor subtypes have been 
suggested to underlie either facilitatory or inhibitory descending control. For example, 
the descending facilitatory pathway from the RVM act ultimately on spinal cord in acute 
and chronic pain states through 5HT3 receptor whereas the inhibitory pathway is 
through 5HT7 (Dogrul et al., 2009; Suzuki & Dickenson, 2005; Suzuki et al., 2004). 
Additionally, several receptors, including the 5HT1 (1A and 1B), 5HT2 (2A and 2C), 
5HT3, and 5HT4 receptors are expressed in the spinal cord dorsal horn and can produce 
an inhibitory effect on spinal nociception transmission (Liu et al., 2010). As a whole, the 
descending control seems to have an inhibitory effect on spinal neurons under normal 
condition. Loss of descending inhibition after spinal cord transection can contribute to 
hyperexcitability in spinal circuits, resulting in the facilitation of nociceptive reflexes. 
Further, recent research has demonstrated that activation of 5-HT2A receptors 
upregulates KCC2 function and expression through a PKC-dependent mechanism, which 
decreases the intracellular chloride concentration of neuron in the spinal cord, thereby 
increasing the inhibitory tone (Bos et al., 2013; Lee et al., 2011; Medina et al., 2014). 
These results parallel my finding that membrane-bound KCC2 was decreased by 
internalization after spinal transection (loss of descending control). Taken together, it is 
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clear that the transection-induced switch of GABAergic signaling is due to the lack of 
descending control from the brain. This work also confirms that descending inhibition 
from the brain is a key regulator for the neuronal plasticity of pain sensation in the CNS. 
Clinical Implications 
The regulation of GABA function by [Cl-]intra may be an important therapeutic 
strategy for treating pain or neurological disorders. For painful diabetic neuropathy, 
Jolivalt et al. (2008) has shown that KCC2 downregulation and increased GABA release 
contribute to spinally-mediated hyperalgesia in diabetes. The KCC2 downregulation and 
the consequent [Cl-]intra elevation have also been related to neuropathic pain (Coull et al., 
2003), spasticity following SCI (Boulenguez et al., 2010), and adult neurogenesis (Ge et 
al., 2006). These studies imply that impaired KCC2 function is the principal cause of the 
[Cl-]intra increase that subsequently lead to the depolarizing effect of GABA. Although 
the primary cause and mechanisms of KCC2 downregulation are still not fully-
understand, further research focusing on the signaling pathways upstream the 
expressional change of KCC2 or even NKCC1 should reveal strategies to treat pain or 
neurological disorder. 
Summary 
Maladaptive pain is associated with injury to a peripheral nerve or the central 
nervous system (neuropathic pain). Central sensitization, a hyperactive state of 
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nociceptive neurons within dorsal horn of the spinal cord, has been suggested as a 
possible causal mechanism of neuropathic pain, which is manifested as allodynia and 
hyperalgesia. This dissertation examined one of the mechanisms, reduction of inhibition, 
that contributes to the increased synaptic efficacy and the central sensitization of the 
somatosensory pathway. I showed that GABA can have excitatory effect after spinal 
transection, when the descending input from the brain has been disrupted. Other research 
has shown that GABA is also excitatory in neonatal CNS (Ben-Ari, Khalilov, Kahle, & 
Cherubini, 2012), and that this effect contributes to neurite growth in mature CNS (Ge et 
al., 2006), and allodynia and hyperalgesia in diabetic rats (Jolivalt et al., 2008). Research 
indicates that KCC2 expressional changes underlie the excitatory effect of GABA. 
Further, regulatory action of BDNF has also been linked to the expressional change of 
KCC2. In mature neurons, application of exogenous BDNF induces a down-regulation 
of the KCC2 function, whereas application of BDNF to immature hippocampal cultures 
significantly increases the expression of KCC2 (Medina et al., 2014). SCI-induced 
switch of GABAergic system is probably linked to the developmental switch of GABA 
from excitatory to inhibitory during the postnatal period. Under pathological condition in 
mature neurons, the down regulation of KCC2 may reflect a rejuvenation of the system 
which emulates neonatal circumstance for neurite regrowth and re-establishment of the 
damaged tissue. This may be a prerequisite for the repair and recovery of the system 
after SCI.  
In summary, the descending input from the brain, probably through dorsal 
funiculus, is crucial for maintaining GABAergic inhibition. By regulating the balance of 
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the potential across cell membrane by KCC2 expressional change or interaction with 
other metabotropic receptor (mGluR1), GABA can have a dual effect and thereby 
enhance or diminish neuropathic pain after SCI. The switch in GABA function after SCI 
enables the CNS to mimic neonatal-like circumstance where GABA is excitatory. This 
can be beneficial for lesion repair and neurite regrowth after SCI. GABAergic system is 
important in controlling neuronal homeostasis and is involved in many neurological 
disorders. Understanding how GABAergic system is modified by SCI is important to 
deriving more effective methods to treat pain. As mentioned before, the primary 
mechanisms initiating KCC2 downregulation during pathologies are still not well 
understood. Further studies are needed to explore the underlying mechanisms, as well as 
creating new agents that target KCC2-related signaling pathways. 
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Figure 27. Hypothetical model of depolarizing GABA after SCI.  
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